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Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation 
and swelling of the joints.  Middle ear joints may be subject to rheumatic involvement 
similar to other joints in the body.  Results from previous studies examining 
audiological characteristics in individuals with RA have varied with respect to 
incidence and type of hearing loss, as well as incidence and type of middle ear 
involvement (increased or decreased stiffness). The purpose of this study was to 
compare audiometric, immittance, distortion-product otoacoustic emission (DPOAE), 
and energy reflectance (ER) results between participants with RA and normal control 
(NC) participants to further examine the effects of RA on middle ear function. 
Twenty-one participants with RA (38 ears) were matched 1:1 based on age and 
gender to 21 individuals (38 ears) without RA.  The following measures were 
completed for all participants: pure-tone air- and bone-conduction thresholds, 226-, 
  
678- and 1000-Hz tympanograms, acoustic reflex thresholds, acoustic reflex decay, 
and middle ear resonant frequency.  ER and DPOAEs were measured for a subset of 
16 RA (28 ears) and 16 NC (28 ears) matched participants.  No significant difference 
in prevalence of hearing loss was found between groups.  Individuals with hearing 
loss in both groups presented with sensorineural-type hearing loss, which was 
typically a mild to moderate high-frequency hearing loss.  No significant differences 
were found between groups for air- and bone-conduction thresholds.  A significantly 
greater number of ears from the RA group had thresholds poorer than the 95th 
percentile for their age range and gender across the audiometric test frequencies.  
Generally, younger individuals with RA had poorer thresholds at 1000 and 2000 Hz 
compared to normative data for age and gender.  No differences were found between 
groups for static admittance, the number of notched versus single-peaked 678- and 
1000-Hz tympanograms, acoustic reflex thresholds, ER, and DPOAE measurements. 
The RA group had a significantly lower mean resonant frequency, consistent with an 
increase in the laxity or an increase in the mass dominance of the middle ear system.  
These significant findings revealed the importance of considering audiological 
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Chapter 1: Introduction 
Rheumatoid arthritis (RA) is an autoimmune disease which causes 
inflammation and swelling of the joints, and may cause the surrounding muscles, 
ligaments, and tendons that support the joint to become weak, loosened, or unable to 
function normally.  The two joints located in the middle ear (incudomalleolar and 
incudostapedial) are freely movable joints called diathroses; and, therefore, may be 
subject to rheumatic involvement similar to other joints in the body.   
Multiple authors have reported a higher incidence of hearing loss in 
individuals with RA (28 – 60%) compared to normal controls (Heyworth & Liyanage, 
1972; Kakani, Mehra, & Mehta, 1990; Kastanioudakis, Skevas, Danielidis, Tsiakou, 
Drosos, & Moustopoulos, 1995; Magaro et al., 1990; Özcan, Karakus, Gündüz, 
Tuncel, & Sahin, 2002; Öztürk et al., 2004; Salvinelli et al., 2004); however, the type 
of hearing loss documented has varied  (Kastanioudakis et al., 1995; Magaro et al., 
1990; Raut, Cullen, & Cathers, 2001; Salvinelli et al., 2004).  Conductive, mixed and 
sensorineural hearing loss have been reported in RA populations (Copeman, 1963; 
Djupesland, Grønås, & Saxegaard, 1973; Gairola, Kacker, Kumar, & Malaviya, 1991; 
Heyworth & Liyanage, 1972; Raut et al., 2001; Salvinelli et al., 2004).  The most 
prevalent type of hearing loss reported has been sensorineural hearing loss (Elwany, 
Garf, & Kamel, 1986; Kakani et al., 1990; Kastanioudakis et al., 1995; Magaro et al., 
1990; Reiter, Konkle, Myers, Schimmer, & Sugar, 1980; Takatsu, Higaki, Kinoshita, 
Mizushima, & Koizuka, 2005).  The cause of damage to the inner ear is not clearly 




ear function may be associated with the greater presence of hearing loss (Elwany et 
al., 1986; Özcan et al., 2002; Raut et al., 2001). 
In addition to a high rate of hearing loss originating in the inner ear, 
researchers have reported significant differences between individuals with RA and 
NC participants (Elwany et al., 1986; Öztürk et al., 2004; Reiter et al., 1980; Takatsu 
et al., 2005).  Studies have reported as many as 59-70% of RA participants having 
abnormal middle ear function (Elwany et al., 1986; Reiter et al, 1980).  Clinical 
immittance measures, including single- and multiple-frequency tympanometry, have 
indicated differences in the transmission of sound through the middle ear, including 
both increased stiffness (Elwany et al., 1986; Kakani et al., 1990; Öztürk et al., 2004; 
Reiter et al., 1980; Takatsu et al., 2005) and laxity (Moffat, Ramsden, & Rosenberg, 
1977; Rosenberg, Moffat, Ramsden, Gibson, & Booth, 1978) of the middle ear 
system.  The changes in the stiffness of the middle ear system are believed to be 
associated with RA involvement of the ossicular articulations (Salvinelli et al., 2004).  
However, these abnormalities in middle ear sound transmission do not always result 
in a conductive type of loss.  Researchers hypothesize that some of these changes in 
sound transmission may be related to the increased rate of sensorineural hearing loss 
observed in patients with RA because the changes affect the protective mechanism of 
the middle ear (Öztürk et al., 2004; Salvinelli et al., 2004); however, the impact of 
RA on the auditory system remains the subject of debate.   
Existing research on the effect of RA on the auditory system has utilized 
standard clinical measures of middle ear function, including tympanometry and 




frequencies through the middle ear (200-2000 Hz).  Energy reflectance (ER) allows 
evaluation of power transfer through the middle ear over a broader frequency range.  
This method may provide increased sensitivity to subtle changes in the efficiency of 
energy transfer through an auditory system affected by RA.  The purpose of this 
research is to study the effects of RA on middle ear function in adults using multi-
frequency tympanometry and ER, in addition to traditional audiometric and 













Chapter 2: Literature Review 
Rheumatoid Arthritis (RA) 
Overview 
RA is an inflammatory disease that affects the joints.  It is an autoimmune 
disease that causes the white blood cells to travel to the tissue lining the joint capsules 
and cause inflammation. In healthy individuals, the immune system protects the body 
from infection and disease; however, in individuals with RA, the immune system 
attacks joint tissues. The tissue lining the joints, called synovium, produces synovial 
fluid that lubricates the joint capsules.  When the synovium is inflamed, it can cause 
redness, swelling, stiffness, and pain around the joint (Hunder, 1999).  As a result of 
RA, the normally thin synovium may grow into a thick, abnormal tissue called 
“pannus,” making the joint swollen and painful to move.  As the disease progresses, 
the inflamed synovium can damage the cartilage and bone within the joint, and may 
cause the surrounding muscles, ligaments, and tendons that support the joint to 
become weak, loosened, or unable to function normally.  This severe joint damage 
can begin during the first year or two that an individual has the disease (U.S. 
Department of Health and Human Services: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases [NIAMS], 2004). 
RA is estimated to affect approximately 2.1 million people in the United 
States, about 1% of the adult population, and similarly about 1% of the population 
worldwide.  RA affects a variety of races and ethnic groups (Harris, 2005; Silman, 




2-3 times more likely than men to become afflicted with the disease.  Onset typically 
occurs between the ages of 35 and 50 years; however, children and young adults can 
also develop the disease (Cush, Kavanaugh, & Stein, 2005; Silman, 2001).   
Symptoms 
The degree and severity of symptoms of RA varies between individuals.  The 
classic features of RA include warm and tender joints, as well as symmetrical joint 
involvement (U.S. Department of Health and Human Services: NIAMS, 2004).  This 
symmetrical pattern of joint involvement means that if the right wrist is affected, then 
typically the left wrist will be involved, as well.  The wrists, fingers and small bones 
of the hands are the most frequently affected joints; however, ankles, feet, knees, and 
hips are often involved.  RA can involve any diarthrodial joint, also called a synovial 
joint, which is defined as a freely movable joint (Pugh et al., 2000).   
RA has the potential to affect the form and function of many 
otorhinolaryngologic joints, such as the ossicular joints located in the ear, the 
temporomandibular joint, and the cricoarytenoid joints (Gairola et al., 1991; Harris, 
2005; Kovarsky, 1984; Rigual, 1988).  Similar to ossicular joints, the cricoarytenoid 
joint is a true diathrodial joint and a high occurrence of rheumatoid laryngitis has 
been documented (Brazeau-Lamontagne, Charlin, Levesque, & Lussier, 1986; 
Kolman & Morris, 2002; Papadimitraki, Kyrmizakis, Kritikos, & Boumpas, 2004; 
Voulgari, Papazisi, Bai, Zagorianakou, Assimakopoulos, & Drosos, 2005).  Despite 
the prevalence of otorhinolaryngologic complications of RA, the main manifestations 
of the disease often cause ENT symptoms to be overlooked by both patients and 




Individuals with RA often experience morning stiffness, pain and stiffness 
following long periods of rest, in addition to fatigue and fevers (Cush et al., 2005).  
Individuals with osteoarthritis, a type of arthritis that is caused by the breakdown and 
eventual loss of the cartilage in the joints, typically do not experience symmetrical 
joint involvement, general feelings of illness and fever, and warm swollen joints 
experienced by individuals with RA.   
RA is a chronic, progressive disease that varies between and within 
individuals.  Some individuals may have mild and moderate forms of the disease, 
while others can experience severe disease involvement leading to serious joint 
damage and disability.  Individuals with RA often experience periods of worsening 
symptoms and increasing disease involvement, which are referred to as “flares” or 
“flare-ups.”  Similarly, individuals with RA may also experience improving 
symptoms and periods of relief from symptoms, called “remissions” (U.S. 
Department of Health and Human Services: NIAMS, 2004).   
Etiology 
The exact cause of RA is unknown; however, research has identified several 
factors involved with RA.  Persons with certain genetic factors may have a 
predisposition for the development of the disease.  There is an increased rate of 
occurrence in first-degree relatives of patients with RA (Silman, 2001), which is 
approximately four times that of the general population (Cush et al., 2005).              
Environmental factors may also contribute to the development of RA.  While 
the exact triggers are unknown, environmental triggers such as a viral or bacterial 




susceptible  (U.S. Department of Health and Human Services: NIAMS, 2004).  The 
inflammation and joint damage caused by RA is associated with tumor necrosis factor 
(TNF).  TNF is a protein produced by the immune system in response to potential 
toxins, such as endotoxins that originate internally.  Recent treatment options have 
aimed to block TNF action and have proven to be beneficial at improving 
inflammation in individuals with RA (Moots & Jones, 2004). 
Hormonal and gender factors also contribute to an individual’s susceptibility 
to RA.  The higher prevalence of women developing RA suggests an effect of sex 
hormones (Cush et al., 2005; U.S. Department of Health and Human Services: 
NIAMS, 2004).  Pregnancy has also been found to improve RA symptoms in some 
females (Silman, 2001), and symptoms may flare following pregnancy (U.S. 
Department of Health and Human Services: NIAMS, 2004).  In addition to hormone 
levels changing in association with pregnancy, it is believed that the immune system 
molecules interleukin 12 (IL-12) and tumor necrosis factor-alpha (TNF-α) also 
change as a result of pregnancy, contributing to development of RA in susceptible 
individuals (U.S. Department of Health and Human Services: NIAMS, 2004).  
Anecdotal reports have also suggested an influence of menstrual cycle on the severity 
of symptoms associated with RA (Silman, 2001).    
Diagnoses 
There is no single test that diagnoses RA.  Instead, a test battery including 
case history, physical examination, and laboratory tests contribute to the diagnosis of 
the disease.  Due to the similarity of RA symptoms to other diseases such as Reiter’s 




gout, differential diagnosis is important for accurate identification of the disease 
(Cush et al., 2005).  A complete and comprehensive medical history, including the 
patient’s description of symptoms, disease onset, and joint function, are important to 
aid in proper diagnoses.  A physical examination assesses the presence of common 
RA features such as swollen, tender joints and loss of joint function, as well as 
reflexes and muscle strength  (U.S. Department of Health and Human Services: 
NIAMS, 2004). The joints often affected by RA are the following: proximal 
interphalangeal (PIP) joints located at the middle of the finger; metacarpalphalangeal 
(MCP) joints located at the first knuckle of the hand; and metatarsophalangeal (MTP) 
joints located at any of the joints between the metatarsals and the phalanges in the 
foot (Pugh et al., 2000). 
Laboratory tests for RA include testing for rheumatoid factor (RF).  RF is an 
antibody that is present in 75% to 80% of individuals with RA (Cush et al., 2005), 
and is detected by a blood test.  Not all individuals with RA test positive for RF and 
not all individuals who have tested positive for RF develop the disease (U.S. 
Department of Health and Human Services: NIAMS, 2004).  RF is also present in 
individuals with conditions other than RA such as Sjögren syndrome, hepatitis, and 
SLE (Cush et al., 2005).    
Additional laboratory tests are often used to support an RA diagnosis.  A 
blood test is used to check levels of white and red blood cells.  Individuals with RA 
often have a low red blood cell count causing anemia, and a high white blood cell 
count which signals infection in the body (Moots & Jones, 2004).  An erythrocyte 




in the body.  ESR measures how quickly red blood cells fall to the bottom of a test 
tube.  The faster the sedimentation rate, the more inflammation that is present in the 
body.  High sedimentation rates in individuals with RA reflect greater disease 
activity.  C-reactive protein (CRP) testing is also conducted to measure inflammation 
in the body by measuring the amount of CRP produced by the liver.  High levels of 
CRP reflect inflammation in the body, and this test is commonly used to monitor 
inflammatory conditions, such as RA.  A specific type of CRP test, high-sensitivity 
CRP, further evaluates risks for sudden heart problems. Higher levels of CRP reflect 
a greater severity of RA (Moots & Jones, 2004).  ESR and CRP levels measure active 
inflammation and may be helpful for assisting in diagnosis.  These measures are also 
useful to estimate a prognosis as well as to gauge the effectiveness of therapy (Cush 
et al., 2005).   
X-rays and other imaging techniques are employed to assess the degree of 
joint destruction.  Such images can provide information about the swelling of joints 
and the destruction of bone surrounding the joints (Hunder, 1999).  After only months 
of disease involvement, a loss of cartilage and bony erosions may develop.  Within 
the first two years of the disease, 70% of patients will develop bony erosions (Cush et 
al., 2005).  Imaging may also be useful to assess the progression of the disease (U.S. 
Department of Health and Human Services: NIAMS, 2004).   
While the test battery approach helps to contribute to diagnosis of the disease, 
the American Rheumatism Association (ARA) outlined revised criteria in 1987 for 
the classification of RA (Arnett et al., 1988; Silman, 1988).  According to Arnett et al. 




respectively; however, when the evaluation criterion was applied during the first year 
of disease onset, the sensitivity and specificity dropped to 80.9% and 88.2% 
respectively.   
RA can also be classified into active or inactive disease staging.  The inactive 
phase uses the same criterion as active RA, based on the American Rheumatism 
Association (Arnett et al., 1988).  The inactivity of the disease is determined when an 
individual that formerly presented with the classic afflictions is currently 
asymptomatic (Silman, 2001).   
Pharmacological Treatment 
There is no cure for RA but there are a variety of treatment methods and 
approaches.  The goals of treatment approaches are to improve individuals’ 
functionality, relieve pain and inflammation, and slow down or stop joint damage 
(U.S. Department of Health and Human Services: NIAMS, 2004).   
Most individuals with RA take medication to control the disease and to reduce 
pain and inflammation.  Common types of drug treatment include the use of the 
following: disease-modifying antirheumatic drugs (DMARDs) to slow the course of 
the disease (e.g., methotrexate; hydroxychloroquine); non-steroidal anti-inflammatory 
drugs (NSAIDs) to reduce inflammation (e.g., ibuprofen, acetaminophen, aspirin); 
corticosteroids to relieve inflammation and swelling (e.g., prednisone); and biologic 
response modifiers such as TNF inhibitors (e.g., etanercept, infliximab) and 
interleukin-1 inhibitor (e.g., anakinra) that block cytokines, a part of the immune 
system that contributes to inflammation (Moots & Jones, 2004; U.S. Department of 




found in patients treated with large dosages of aspirin, but most individuals’ hearing 
recovers following discontinuation of the drug (Halla & Hardin, 1988).  In addition, 
Kastanioudakis et al. (1995) reported no correlation between sensorineural hearing 
loss and the common antirheumatic medications NSAIDs, D-penicillamine, plaquenil 
and methotrexate.   
 Extra-articular manifestations 
Extra-articular manifestations tend to occur in patients with severe and 
longstanding RA who have tested positive for RF (Moots & Jones, 2004).  Some 
extra-articular manifestations may include heart and lung involvement, muscle 
weakness, nodules, and vasculitis (Harris, 2005; Maini & Feldmann, 1998).  
Rheumatoid nodules are subcutaneous masses consisting of fibrous tissues that can 
vary from a soft mobile mass to a hard, rubbery mass.  While they are not often 
painful, nodules are commonly found in areas susceptible to trauma, such as elbows 
and hands (Maini & Feldmann, 1998), and can range in size from that of a pea to a 
walnut (Hunder, 1999).  Vasculitis is a non-infectious inflammatory disorder 
involving the blood vessels (Maini & Feldmann, 1998).  Vasculitis is usually found in 
the most severely affected individuals and can involve large and small vessels 
(Harris, 2005).  It has been hypothesized that the middle ear changes in RA may be 
associated with vasculitis impacting the blood supply to the incus.  The most 
susceptible part of the ossicular chain is believed to be the long process of the incus, 
which has a tenuous blood supply, and interference with the flow of blood may lead 
to joint erosion and discontinuity (Camilleri, 1991).  Vasculitis may also potentially 




type of hearing loss (Öztürk et al., 2004).  McCabe (1979) first introduced the topic of 
autoimmune sensorineural hearing loss, which has been associated with vasculitis; 
however, this involvement typically produces a rapidly progressive hearing loss that 
may occur suddenly.   
Middle Ear 
Middle Ear: Anatomy 
 
The two joints located in the middle ear, the incudomalleolar and 
incudostapedial, are freely movable diarthrodial joints.  Therefore, the middle ear 
joints may be subject to rheumatic involvement similar to other joints in the body.  
The incudomalleal joint is formed by the articulation of the head of the malleus and 
the head of the incus (Lipscomb, 1996).  This saddle-shaped diarthrodial joint glides 
in response to pressure changes in the normal middle ear (Hüttenbrink, 1998).  The 
incudostapedial joint is formed by the articulation of the long process of the incus and 
the head of the stapes and is a ball and socket joint (Gussen, 1971).  Attached to the 
ossicular chain are the stapedius and tensor tympani middle ear muscles. The 
contraction of the stapedius and tensor tympani muscles, which can be activated by 
vocalizations, chewing, yawning, tactile stimulation, and relatively intense sounds 
(acoustic reflex), stiffens the middle ear system.  One hypothesized function of this 
response is protection of the auditory system by reducing the sound levels that reach 
the inner ear (Sesterhenn & Breuninger, 1978).  A change in this protective function 
is theorized by some researchers as contributing to the higher prevalence of 




 The function of the middle ear system is to transform acoustical energy into 
mechanical energy, and to transmit that mechanical energy to the fluid of the cochlea.  
The ossicular chain and the ossicular joints are important components in the 
transmission of sound through the middle ear system, transmitting and boosting the 
signal received from the tympanic membrane to the cochlea.  This energy transfer 
starts when sound waves enter the ear canal, creating sound pressure, which vibrates 
the tympanic membrane (Wiley & Stoppenbach, 2002). The medial movement of the 
tympanic membrane causes the manubrium of the malleus to move medially, and the 
head of the malleus to move laterally.  This in turn causes the body of the incus to 
move laterally and the lenticular process to move across the head of the stapes, 
pushing the footplate in and out of the oval window.  When the tympanic membrane 
moves laterally, the reverse and opposite phase occurs (Lipscomb, 1996).  The flow 
of energy through the system depends upon the acoustic impedance/admittance of the 
system and the acoustic and mechanical contributions from the anatomic structures in 
the system.  
The middle ear plays an important physiological role in the auditory system’s 
ability to overcome the impedance mismatch between the air in the ear canal and the 
fluid in the cochlea through the area effect, the leverage effect involving the ossicles, 
and the curvature of the tympanic membrane.  Pathology and systemic diseases 
influence the effectiveness of the middle ear transmission of sounds through the 




Middle Ear: Diagnostic Tests 
Immittance Measurement Principles.  Acoustic immittance is a collective term that 
refers to the ease of flow of energy [admittance  (Ya)] in a system, the opposition to 
the flow of energy [impedance (Za)] in a system, or both (American National 
Standards Institute, 1987; Shanks, Lilly, Margolis, Wiley, & Wilson, 1988).    
Factors that affect the opposition with which energy flows through the system 
(impedance) include resistance (R) and reactance (X).  Resistance is the opposition to 
the flow of energy created by friction in the system and causes some of the energy in 
the system to be dissipated as heat.  Reactance is the opposition to the flow of energy 
by parts of the system that store energy and involves the compliance and mass of the 
system (Shanks et al., 1988).   
Resistance properties are affected by air movement and friction created by the 
tendons and ligament of the middle ear (Shanks & Shelton, 1991).  Reactance 
properties are influenced by two components: mass reactance and compliant 
reactance.  Compliant reactance is related to the structures that store energy due to 
their stiffness.  Mass reactance is related to structures that store energy due to their 
inertia or mass.  Factors that influence the compliance or stiffness of the middle ear 
system include the tympanic membrane, round window membrane, ossicular 
ligaments, and middle ear muscles, in addition to the air within the ear canal and 
middle ear cavity. The mass contributions of the middle ear system include the 
ossicles, pars flaccida of the tympanic membrane, and the perilymph in the cochlea 
(Shanks & Shelton, 1991; Van Camp, Margolis, Wilson, Creten, & Shanks, 1986).  




greater for lower frequencies while the effects of mass are greater for higher 
frequencies. The overall impedance of the middle ear system is dependent on a 
combination of the resistance, mass reactance and stiffness reactance components 
(Shanks, 1984).  
Admittance, the reciprocal of impedance, has correlates to the impedance 
components that affect the transmission of energy through the middle ear system.  
Conductance (G) is the reciprocal of resistance and susceptance (B) is the reciprocal 
of reactance (Shanks et al., 1988).  Conductance is independent of frequency, 
whereas, susceptance measurements are frequency dependent.  Mass exerts the 
greatest influence at high frequencies and stiffness exerts the greatest influence at low 
frequencies (Wiley & Stoppenbach, 2002).  These components influence the ease of 
energy flow through the ear.  Current immittance instruments measure the admittance 
of the middle ear system.  Clinically, an acoustic immittance test battery includes 
tympanometric and acoustic reflex measurements, to assess the functioning of the 
middle ear system. 
Single-frequency tympanometry. Tympanometry is an objective measure that 
records the changes in acoustic immittance in the external ear canal in response to air 
pressure changes in the ear canal (Shanks et al., 1988).  Since the commercial 
development of an acoustic-impedance bridge in 1963 (Zwislocki, 1963) and the 
publication of the first clinical paper by Jerger (1970), single frequency 
tympanometry has routinely been used clinically to assess middle ear function.  
Tympanometry most commonly measures the admittance of a signal through the 




The most simple and common form of tympanometry utilizes a single probe 
tone of 220- or 226-Hz (Lilly, 2005).  Low frequency tympanograms have been 
interpreted by the classification of tympanometric shape (Jerger, 1970; Jerger & 
Jerger, 1974; Liden, 1969; Vanhuyse, Creten & Van Camp, 1975), or by quantitative 
measurements comparing tympanometric width, equivalent ear canal volume and 
static admittance to available normative values (Shanks et al., 1988).  The most 
popular classification method was proposed by Jerger (1970), which categorizes 
tympanograms based on shape.  Type A tympanograms have peak pressures near 
atmospheric pressure, and are further classified according to peak height: As are 
described as shallow tympanograms due to reduced peak height; Ad are described as 
deep tympanograms due to increased peak height; and A are described as normal due 
to normal peak height.  The type B tympanogram does not have a measurable peak 
and is flat or round in shape, and the type C tympanogram has a normal peak height 
but negative peak pressure.  Figure 1 displays an example of a Type A (normal) 
tympanogram, which was obtained from a participant in this study. This classification 
scheme provides a gross description of measurements, and remains popular today 
despite its limitations and the availability of quantitative measures (Fowler & Shanks, 
2002).     
Tympanograms are often analyzed based on comparison of quantitative 
values, as opposed to only shape classification.  These quantitative measures include 
peak compensated static admittance (height of the tympanogram at which the peak 









Figure 1. Type A (normal) tympanogram recorded using a 226 Hz probe tone from a 
59 year-old male participant in the RA group from the current study.  Single-
frequency (226 Hz) tympanograms are typically plotted with admittance (shown here 







occurred), and tympanometric width (pressure interval of the tympanogram at the 
50% reduction in peak admittance).  Figure 2 highlights the quantitative measures of 
a normal tympanogram obtained from a participant in the current study.  
A normal range of peak compensated static admittance in adults is 0.3 – 1.7 
ml (Margolis & Goycoolea, 1993).  Tympanometric width is considered normal in 
adults if it is within a range of 51 – 114 daPa (Margolis & Heller, 1987).  
Tympanometric width is not widely used clinically in adult populations, and has been 
more regularly used in detecting middle ear effusion in children (Nozza, Bluestone, 
Kardatze, & Bachman, 1992).  The TPP is the pressure at which the greatest amount 
of energy is admitted into the middle ear.  This is assumed to occur when the pressure 
in the ear canal is equivalent to that in the middle ear; and, therefore, TPP is used as 
an estimate of middle ear pressure.  This measure is often used to assess Eustachian 
tube functioning.  Poor Eustachian tube functioning often results in negative pressure 
in the middle ear and, therefore, a negative TPP. 
Tympanometry conducted with a single, low-frequency probe tone has proven 
validity in assessing Eustachian tube function and in identifying tympanic membrane 
abnormalities (e.g., excessive scarring, perforations) and certain middle ear 
pathologies (e.g., middle ear effusion) (Onusko, 2004; Shahnaz & Polka, 1997).  
These measurements have been particularly helpful in the evaluation of young 
children who are prone to otitis media (Jerger, 1970; Onusko, 2004), but using a 
single frequency probe tone has several limitations.   
Results obtained using 226-Hz tympanometry are dominated by the 







Figure 2. Quantitative measures for a normal 226-Hz tympanogram recorded from a 
59 year-old male participant in the RA group from the current study.  Measure 1 
identifies the tympanometric peak pressure (TPP) of –5 daPa.  Measure 2 identifies 
the peak compensated static admittance of 0.6 ml.  Measure 3 identifies the 







the function of the ossicular chain (Shahnaz & Polka, 1997).  Additionally, a 
standard, single, low-frequency tympanogram does not accurately distinguish ears 
with normal middle ear function and ears with otosclerosis, a pathology that causes a 
stiffening of the middle ear (Colletti, 1976; Hunter & Margolis, 1992).  
The inadequacies of single frequency tympanometry are due in part to limited 
information provided about the middle ear, which is a frequency dependent system 
(Colletti, 1976; Hunter & Margolis, 1992).  Low frequency tympanometry assesses a 
normally functioning middle ear when it is a stiffness-dominated system, meaning 
that the middle ear has greater compliance reactance than mass reactance.  Similar to 
how a threshold measured at 500 Hz provides insufficient information about the 
hearing sensitivity of the auditory system, a single probe tone provides insufficient 
information about sound transmission through the middle ear system. 
Multiple frequency tympanometry. Additional tympanometric measures can 
be obtained using higher probe tone frequencies up to 2000 Hz.  Commonly used 
additional frequencies are at 660/678- and 1000-Hz.  Tympanograms obtained using 
higher probe tone frequencies are often analyzed according to shape because they can 
have a variety of configurations, unlike the typical single peak found in normal adults 
for low-frequency probe tones.  Low-frequency probe tone tympanograms most often 
measure admittance.  As previously discussed, there are several factors that contribute 
to the admittance measured: stiffness and mass (susceptance) and friction 
(conductance) of a system.  Susceptance (B) and conductance (G) tympanograms are 
often measured separately at higher frequency probe tones due to the greater 




Liden (1969) first described the multipeaked or notched configurations of 
multi-frequency tympanometry.  Vanhuyse et al. (1975) created a classification model 
to explain the shapes obtained from tympanograms recorded at 678-Hz.  Margolis, 
Van Camp, Wilson, and Creten (1985) extended the model to compare tympanograms 
recorded at different probe frequencies.  The authors found tympanometric shapes 
followed an orderly progression as frequency increased, and produced more complex 
patterns at higher probe frequencies. The notching (“W” shape) of the tympanogram 
indicates the middle ear system becoming progressively more mass dominated 
(Shanks et al., 1988).  The susceptance (B) tympanogram is expected to notch first as 
frequency is increased, followed by the conductance (G) tympanogram.  There are 
four classic Vanhuyse et al. (1985) patterns based on the number of maxima and 
minima peaks: 1B1G, 3B1G, 3B3G, and 5B3G.  Examples of the some of these 
tympanogram types are shown in Figures 3, 4 and 5.   
When the middle ear system is stiffness controlled, the susceptance 
component is positive. When the middle ear system is mass controlled, the 
susceptance component is negative. This model suggests that if the susceptance 
tympanogram is either un-notched or notches and the center of the notch is above the 
tail value, then the middle ear is stiffness-dominated.  In contrast, if the tympanogram 
notched and the center notch is below the tail value, then the middle ear is mass-
dominated.  When the susceptance notch is equal to the tail value, then the mass and 
compliance are equal and the middle ear is in resonance. 
The resonant frequency is the frequency at which mass and compliance 









Figure 3.  Example of a 1B1G type pattern from data obtained by the current study, 
and classified based on Vanhuyse et al. (1975).  Single peaked tympanograms without 
the presence of notching were observed at 678-Hz in this 58 year-old female 
participant from the NC group.  The susceptance curve (B) is on top and the 













Figure 4.  Example of a 3B1G type pattern from data obtained by the current study, 
and classified based on Vanhuyse et al. (1975).  Notching was observed in the 
susceptance curve at 678-Hz in this 58 year-old female participant from the NC 
group, while the conductance curve remained single-peaked.  The susceptance curve 













Figure 5.  Example of a 3B3G type pattern from data obtained by the current study, 
and classified based on Vanhuyse et al. (1975).  Notching was observed in both the 
susceptance and conductance curves at 1000-Hz in this 59 year-old female participant 
from the RA group.  The susceptance curve (B) starts at +200 daPa on top and the 









however, standard clinical immittance equipment typically assesses resonant 
frequency by using either a sequential frequency sweep or a sequential pressure 
sweep to determine the point at which compensated susceptance is equal to zero 
(Shanks et al., 1988).  The method used to determine the resonant frequency, 
frequency sweep or pressure sweep, can influence the values obtained (Shanks, 
Wilson, & Cambron, 1993). 
According to Colletti (1976), the average normal adult middle ear resonance is 
approximately 1000-Hz; however, studies have found a large range of normal values.  
Using a sweep frequency method, the 90% range for compensated resonant 
frequencies has varied. Margolis and Goycoolea (1993) reported a range of 800-2000 
Hz in 28 adults aged 19-48.  Hanks and Mortensen (1997) reported a range of 650-
1300 Hz in 53 young adults aged 18-25.  Holte (1996) reported a range of 630-1250 
Hz in 144 adults aged 20-90.  Shahnaz and Davies (2006) reported a range of 500-
1120 in 76 young adults aged 18-34.  In theory, a pathology that increases the 
stiffness of the middle ear system, such as otosclerosis, should cause the middle ear 
impedance to remain dominated by stiffness over a broader frequency range than 
normal, and thus causes the resonant frequency of the middle ear to be higher than 
normal.  Conversely, a pathology that increases the laxity of the middle ear system, 
such as ossicular discontinuity, should cause the middle ear impedance to become 
mass controlled and the resonant frequency will be lower than normal (Shanks et al., 
1988).    
The use of multifrequency tympanometry and determination of resonant 




1976; Hunter & Margolis, 1992; Shahnaz & Polka, 1997).  Resonant frequency is 
more sensitive than 226-Hz tympanometry for identification of ears with otosclerosis 
and ossicular discontinuity (Hunter & Margolis, 1992; Shahnaz & Polka, 1997; 
Valvik, Johnsen, & Laukli, 1994).  Additionally, peak static admittance values of 
higher-frequency tympanograms may also be compared to normative values 
(Calandruccio, Fitzgerald, & Prieve, 2006; Shahnaz & Davies, 2006) to provide 
further clinical utility.  However, there is limited normative data available. 
Additionally, there are limitations in the diagnostic abilities of multifrequency 
tympanometry.  One issue is the wide range of normal middle ear resonant 
frequencies (Valvik et al., 1994).  Valvik et al. (1994) compared resonant frequencies 
from individuals with tympanosclerosis, otosclerosis, and stapedectomy to a group of 
normal individuals.  While statistically significant differences were measured 
between groups, large overlap occurred across groups with the normal ears ranging 
from 350-1750 Hz.  However, the inclusion criteria for the normal controls were not 
clearly defined.  The test-retest reliability was within 150 Hz for most individuals, 
although larger test-retest differences were found in several participants.  The authors 
believed these differences were attributable to a flat susceptance slope close to the 
point at which susceptance is equal to zero, resulting in small variations causing a 
change in resonant frequency.   
When examining the fine structure of the middle ear resonance, Hocke et al. 
(2000) found there may be more than one resonant frequency, possibly helping to 
explain the broad range of normal results and the difficulties with using middle ear 




is the limited frequency range of 200 – 2000 Hz.  Frequencies above 2000 Hz cannot 
be evaluated using tympanometry due to difficulties encountered from distortion of 
acoustic sources, precise impedance calibration, and standing waves (Allen, 1986).  
Therefore, multi-frequency tympanometry cannot be tested at these higher 
frequencies due to artifact (Holte & Margolis, 2002).  
Wideband Reflectance 
 
Wideband reflectance is a more recent approach for measuring middle-ear 
function.  It allows assessment of middle ear function over a broader frequency range, 
including frequencies above 2000 Hz.  Wideband reflectance was first introduced by 
Allen (1985) who described a system capable of measuring the impedance magnitude 
using Thevenin parameters for the acoustic source transducer, allowing the 
impedance to be calculated from the pressure measured in the delivery tube.  Allen 
was able to measure impedance magnitude up to 33,000 Hz in cats.     
The reflectance of the middle ear system is estimated by comparing the 
impedance at the probe tip (using Thevenin values) and the characteristic impedance 
of the ear canal (Feeney, 2005).  Wideband reflectance measurements can examine a 
variety of sound transmission properties including energy transmittance, power 
absorption, and ER.  When measuring ER, there are two basic sound waves in the ear 
canal: (a) the sound from the probe traveling toward the tympanic membrane; and (b) 
the sound reflected by the tympanic membrane traveling outward.  The reflection 
coefficient, r, is the ratio of these two waves, (b/a) (Feeney, 2005).  ER is calculated 
as its magnitude squared, |R|2, and represents the ratio of reflected to incident energy 




energy transmittance, is equal to one minus the energy reflectance (Feeney, 2005).    
To date, ER is the most commonly analyzed measurement of wideband reflectance 
and the majority of the research has examined results using ER.   
ER values can range from 0.0 to 1.0 (Keefe, Ling, & Bulen, 1992) and may 
also be presented as a percentage based on the operating system used (Mimosa 
Acoustics, 2005).  An ear with high impedance would reflect energy from the middle 
ear, and the reflectance would be very high (close to 1.0 or 100%).  A middle ear that 
easily absorbs energy would reflect little to no energy, and the reflectance would be 
very low (close to 0.0 or 0%).  Figure 6 shows an example of a typical ER 
measurement obtained in a participant from the NC group in this study.  Figure 7 
shows an abnormal ER measurement from an excluded participant that presented with 
negative tympanometric peak pressure of –280 daPa, which was well outside the 
inclusion criteria of ±10 daPa tympanometric peak pressure required in this study.   
The “abnormal” ear displayed in Figure 7 has low reflectance values 
throughout the low-frequencies, suggesting more sound is absorbed than in a 
“normal” ear.  The reflectance pattern also produced an atypical configuration with 
multiple peaks at high frequencies.  This demonstrates that the sound reflected by the 
middle ear varies considerably in the high frequencies.  The differences between 
these two figures reflect the importance of accounting for middle ear pressure.  ER 
measurements are typically obtained at ambient pressure. 
Based upon Allen’s measurement system (1985), several researchers have 
since measured ER in humans and determined ER was accurate at frequencies over 



















Figure 6.  ER measurement recorded from a 42 year-old female from the NC group in 
this study.  This figure represents a “normal” ER response.  The three, thin, 
overlapping lines represent the three ER test runs.  The average of three runs is used 
to calculate the ER for data analyses.  The thick line represents normative data from 






















Figure 7.  ER measurement recorded from a 41 year-old female who was excluded 
from this study due to negative tympanometric peak pressure (-280 daPa), as recorded 
by a 226-Hz tympanogram.  This figure represents an “abnormal” ER response.  The 
thin, overlapping lines represent each ER run.  The thick line represents normative 







1994).  Keefe et al. (1992) used the Thevenin approach to measure data on closed, 
cylindrical tubes.  Results indicated this approach was a well-suited approach for 
measurement in human ear canals.  This led to studies measuring ER in adult 
populations, as well as populations such as infants in which standard immittance 
measures have proven difficult to use. 
Normative Values in Adults 
 Keefe et al. (1993) and Voss and Allen (1994) measured ER in humans and 
established a basis of adult normative values for future studies.  Keefe et al. (1993) 
measured impedance and reflection coefficients in 10 adults and reported that the 
least amount of energy was reflected around 3000-4000 Hz and the most around 7000 
Hz.  This showed that a normal ear absorbed the most sound around 3000-4000 Hz.  
Voss and Allen (1994) reported similar ER values in their study of 10 normal hearing 
young adults, but reported a large amount of intersubject variability.  However, 
neither study reported measurements of middle ear pressure, which can affect ER 
measurements obtained at ambient pressure.  
Similar findings were reported for normal adults by Margolis, Saly, and Keefe 
(1999), Feeney, Grant and Marryott (2003), Feeney and Sanford (2004) and Shahnaz 
and Bork (2006).  These researchers measured the averaged ER values across 20, 75, 
and 40 ears, respectively.  The group mean results indicated high ER in the low 
frequencies, lowest ER values around 4000 Hz, and increasing ER values at higher 
frequencies.  Preliminary studies have examined the test-retest reliability of ER 
measurements and good test-retest reliability was reported (Hunter, 2004; Vander 




ambient pressure were similar, although some differences were found. This may be 
due to differences in equipment.  Shahnaz and Bork (2006) were the only 
investigators to use a commercially available reflectance system, Mimosa Acoustics.  
All other studies used a system developed by Keefe et al. (1992).  Differences may 
also be attributed to participant selection.  Feeney et al. (2003) and Feeney and 
Sanford (2004) reported using only individuals with TPP ±10 daPa.  In Margolis et al. 
(1999) and Shahnaz and Bork (2006), the researchers did not report the TPP values 
for their participants.  Participants with TPPs that deviate significantly from ambient 
pressure may have impacted the results.  The variance across studies may also be due 
to varying sample sizes, and the different age distribution of participants. 
When comparing normative data, it is also important to consider potential 
effects of aging.  Currently, only Feeney and Sanford (2003, 2004) have studied 
potential effects of advanced age on middle ear function using ER.  The authors 
compared 40 young adults (aged 18 – 28) and 30 older adults (aged 60-85), and 
examined 226-Hz tympanometry and ER.  While they found no effects of aging using 
226-Hz tympanometry, they observed significant differences between older and 
younger adults on ER and impedance values measured by the ER system. The study 
found a decrease in ER from 800 to 2000 Hz, and an increase around 4000 Hz.  The 
older adult group exhibited less ER at frequencies below the point of least ER, and 
more ER above the point of least ER, suggesting a decrease in the stiffness of the 




Energy Reflectance (ER) and Middle Ear Disorders 
ER has many potential benefits for evaluating middle ear disorders.  Much of 
the work in this area has been focused on ER measures in patients with otitis media 
(OM).  The effectiveness of ER as a clinical tool to identify a conductive hearing loss 
was studied by Piskorski, Keefe, Simmons and Gorga, (1999).  In this study, the test 
group was comprised of 92 children aged 2-10 years who were seen at the Boys 
Town National Research Hospital ENT clinic.  Children with symptoms of otitis 
media were compared to asymptomatic children.  However, the presence or absence 
of a conductive component was not confirmed with an otologic exam, but rather 
based solely on the presence of an air-bone gap determined by masked bone-
conduction thresholds, which can be difficult to assess in young children.  The 
effectiveness of ER measurements obtained at ambient pressure was compared to a 
226-Hz tympanogram.  Comparing the tests separately, the ER responses alone better 
predicted the presence of a conductive hearing loss than tympanometry alone.  In 
addition, the authors found that ER scores at 2000 and 4000 Hz more accurately 
predicted a conductive impairment than at 500 Hz, supporting the hypothesis that the 
2000-4000 Hz frequency range is a sensitive indicator of middle ear function.        
The ability of ER to predict conductive hearing loss was expanded to include 
older children and adult populations by Keefe and Simmons (2003).  The authors 
examined acoustic transfer function measurements obtained at ambient-pressure and 
pressurized conditions, and compared them to 226-Hz tympanometry to assess the 
predictive accuracy of each measurement. Using acoustic transfer functions such as 




(2003) compared 42-normal ears (ages 10-48, M = 19.2 years) and 18-hearing-
impaired ears (ages 11-55, M = 30.3 years).  The ages of the two groups were not 
comparable, and the group with normal ears was younger overall.  The hearing-
impaired ear group included those with sensorineural, mixed and conductive hearing 
losses.  The nature of the conductive hearing losses was not known for this study; 
therefore, results were examined only for the ability to detect a conductive hearing 
loss and not to diagnose the type of conductive hearing loss.  Both acoustic transfer 
function measurements, ambient pressure and pressurized conditions, were more 
sensitive predictors of conductive hearing loss than standard tympanometry. While 
the pressurized measurements may have even more accuracy when identifying 
disorders that involve negative middle ear pressure, ambient pressure measurements 
were sufficiently accurate to use as a hearing-screening application.                
 The detection of otitis media with effusion (OME) in children with ER 
measurements has many advantages over conventional clinical measurements.  
Hunter (2004) reported significantly higher ER in children from birth to 2 years of 
age with middle ear effusion, compared to children without effusion and with normal 
middle ear function.  The authors suggested this measure might improve test 
performance over standard tympanometry.  Jeng, Levitt, Lee and Gravel (2001) used 
ER measurements to compare the ears of three children with OME to 15 children with 
normal ears aged 2.5-5 years of age.  They found that generally ears with OME 
showed less power absorption, and close to zero absorption below 1000-Hz, 
indicating the increased stiffness caused by the pathology in the low frequencies.  




those observed in the control group.  However, due to the small sample size of 
impaired ears in this preliminary study, it is difficult to draw strong conclusions. 
These preliminary data suggest that wideband reflectance provides more frequency-
specific information regarding the peripheral auditory system as well as a better 
understanding about the transmission of sound across a broader range of frequencies 
important for speech.  ER measurements in patients with OM have reflected increased 
ER, consistent with this pathology, which reduces the flow of energy through the 
middle ear.   
Several studies have examined the effectiveness of ER as an identification 
tool in the presence of OM or OME; however, few studies have examined other 
middle ear disorders.  Feeney et al. (2003) studied the ability of ER to detect a variety 
of middle-ear disorders.  This study assessed middle ear ER at ambient-pressure in 10 
adults: two individuals with sensorineural hearing loss (one with normal middle ear 
pressure and the other with negative middle ear pressure), and conductive losses 
caused by a variety of conditions, including otitis media with effusion, otosclerosis, 
disarticulation of the ossicular chain, hypermobility of the tympanic membrane, and 
perforation of the tympanic membrane.  These individuals were compared to 40 
young adults with normal hearing.  The ER measurements for the individual with 
otitis media indicated that nearly all energy was reflected back at frequencies from 
250-3000 Hz, similar to the findings of Jeng et al. (2001).  In the two cases of 
otosclerosis, ER results were abnormal, exhibiting a higher-than-normal ER at 
frequencies below 1000-Hz.  ER was more sensitive to the presence of otosclerosis 




However, the limited number of participants makes it difficult to draw strong 
conclusions.  ER measurements for the case of ossicular discontinuity exhibited a 
low-frequency notch at 678-Hz.  In addition, the ears of individuals with tympanic 
membrane perforations absorbed a great deal of energy in the low frequencies, but in 
the higher frequencies results were near normal.  The individual with negative middle 
ear pressure (-105 and –155 daPa) produced high ER in the low frequencies, 
reflecting most of the sound energy. This pattern was similar to the individuals with 
otosclerosis, demonstrating the importance of a correction for middle ear pressure.  
The results from this study suggest that ER is a promising tool for diagnosis of 
middle-ear disorders, but that more information is necessary.  
Data from Allen, Jeng, and Levitt (2005) also suggest that ER may aid in 
identification of middle ear disorders.  While this study mainly served as a review of 
the development of the Mimosa Acoustics System, a commercially available ER 
measurement tool, it also compared an individual with otosclerosis and an individual 
with a perforated tympanic membrane to a normal control.  In the otosclerotic ear, the 
stiffening of the ossicles caused a large amount of the energy to be reflected back, as 
compared to normative values around 2000 Hz.  Between 400 and 2000 Hz the 
normalized resistance in the otosclerotic ear was significantly below that of normal 
middle ear resistance, and comparable to the results obtained by Feeney et al. (2003).  
The individual with an eardrum perforation exhibited an erratic power ER pattern that 
varied widely across frequencies compared to normative values, particularly in the 
higher frequency range.  However, this varied from the results of two ears with 




display erratic patterns, the low frequency ER range differed between studies.  Allen 
et al. (2005) reported high ER at 200 to approximately 750 Hz, and was more similar 
to normative data than to Feeney’s results.  Feeney et al. (2003) reported almost no 
ER in the same low-frequency range, but his results were different between the two 
ears tested.  The results between studies were more comparable above 1000 Hz.   
The use of ER measurements has also been extended to examine the 
relationship between higher frequency middle ear function and hearing sensitivity.  
ER measurements were used to compare individuals with varying thresholds at ultra-
high frequencies (8000-20,000 Hz) with and without a history of chronic otitis media.  
Margolis, Saly and Hunter (2000) compared three groups of children:  group one 
included 12 ears from eight children without a history of otitis media; group two 
included 29 ears of 24 children with a history of otitis media and better ultra-high 
frequency hearing compared to the group three; and group three included 29 ears of 
25 children with a history of otitis media and poorer ultra-high frequency hearing 
compared to group two.  The authors found no differences in middle ear impedance 
and ER between groups.  The use of ER was helpful in supporting the hypotheses that 
the extended high frequency hearing loss related to otitis media is cochlear in origin.  
Additional studies are needed to assess larger groups with a variety of middle 
ear disorders.  The research examining a range of middle ear disorders is limited to a 
few studies, which did not make statistical comparisons due to small sample sizes 
(Allen et al., 2005; Feeney et al., 2003).  These studies made comparisons of the 
general shape of the ER frequency curves between individuals with middle ear 




considered preliminary in nature (Hunter, 2004; Jeng et al., 2001; Vander Werff & 
Prieve, 2004).     
Despite the limited amount of research, the studies that have been conducted 
indicate the promise of ER as a more sensitive measure than standard tympanometry 
to detect changes in the middle ear system and the presence of middle ear disorders.  
ER has demonstrated benefits for testing difficult populations such as infants, due to 
the system’s capability to test a higher frequency range.  The ability of ER to identify 
middle ear disorders that are often missed by standard middle ear measures, such as 
otosclerosis, demonstrates the potential benefits of the system to elucidate and clarify 
middle ear abnormalities that may be present, but not typically detected by other 
middle ear measurements.  
Rheumatoid Arthritis (RA) and the Auditory System 
RA and Hearing Loss 
 
 Rheumatic involvement of the auditory system and the potential effects on 
hearing sensitivity has been widely debated.  Researchers have discussed three 
potential causes of hearing loss in individuals with RA: (a) rheumatic involvement of 
middle ear joints; (b) sensorineural damage subsequent to neuritis or vasculitis; and 
(c) ototoxicity of drug treatments (Elwany et al., 1986; Frade & Martin, 1998; 
Kastanioudakis et al., 1995; Magaro et al., 1990; Öztürk et al., 2004).  Neuritis is an 
inflammation of the nerve and vasculitis is an inflammation of a blood or lymph 
vessel (Pugh et al., 2000).  Neuritis and vasculitis are potential extra-articular 
manifestations of RA and may affect the cochlea or the cochlear nerve (Magaro et al., 




middle ear, resulting in the decreased mobility of one or both ossicular joints as a 
result of the disease process affecting the blood supply to the lenticular process of the 
incus (Biasi, Fiorino, Carletto, Caramaschi, Zeminian, & Bambara, 1996; Camilleri, 
1991; Colletti, Fiorino, Bruni, & Biasi, 1997; Goodwill, Lord & Knill-Jones, 1972). 
Copeman (1963) was the first to publish an article identifying the link 
between RA and hearing loss.  Copeman studied three patients with RA who had 
fluctuating hearing loss associated with increased disease severity.  Two of these 
participants had documented conductive hearing loss with a negative history of 
middle ear disease.  Copeman hypothesized that the conductive hearing loss was 
caused by an inflammation in the synovial fluid lining the joint articulations in the 
middle ear, interfering with sound transmission.  This claim was strengthened when 
hearing sensitivity improved with a decrease in rheumatic symptoms.  Following 
Copeman’s research, many studies have examined the influence of RA on hearing 
sensitivity.    
General findings across the literature have indicated that individuals with RA 
exhibit a variety of hearing loss types (Özcan et al., 2002; Raut et al., 2001; Salvinelli 
et al., 2004; Salvinelli, D’Ascanio, Casale, Vadacca, Rigon, & Afeltra, 2006).  This is 
not surprising considering the varied potential causes of hearing loss in individuals 
with RA.  Several studies have reported a higher prevalence of sensorineural hearing 
loss compared to normal controls (Goodwill, Lord, and Knill-Jones, 1971 & 1972; 
Kastanioudakis et al, 1995; Magaro et al., 1990).  A higher prevalence of abnormal 




coincide with the presence of sensorineural hearing loss have also been reported 
(Elwany et al., 1986; Reiter et al., 1980; Takatsu et al., 2005).   
Initial studies investigating RA and hearing loss reported a high prevalence of 
hearing loss; however, variables such as salicylate usage and otologic history were 
often poorly controlled.  Heyworth and Liyanage (1972) tested 33 individuals with 
RA, aged 26-83 years old, and found a higher prevalence of hearing loss compared to 
the general population.  For most participants, the reported onset of hearing loss 
occurred after the development of RA.  A variety of hearing loss types were reported.  
The authors accounted for age-related decreases in hearing by classifying subnormal 
hearing based on age-appropriate normative data from Hinchcliffe (1958).  
Audiological results revealed over 36% of the participants presented with hearing 
loss: three participants had a mixed or conductive hearing loss and nine had a 
sensorineural hearing loss.  These researchers did not control for salicylate usage, 
which was believed to have contributed to the cases of sensorineural hearing loss. 
They also did not control for individuals with a significant otologic history, and, 
therefore, may have missed other potential causes of the conductive and mixed 
hearing losses.  Despite these noted limitations, the authors suspected an association 
between RA and hearing loss. 
Djupesland et al. (1973) tested 48 patients with a variety of rheumatic joint 
diseases (RA, juvenile RA, ankylosing spondylitis, psoriatic arthritis), and compared 
results to a normal control group of 50 participants with the same sex and age 
distribution.  The majority (35/48) of the patients were diagnosed with RA.  Overall, 




had a sensorineural hearing loss.  The presence of the conductive hearing loss 
coincided with an abnormal middle ear system as assessed by impedance measures.  
However, the specifics used to define hearing loss and normal middle ear measures, 
as well as the use of statistics were poorly described. The authors attributed the 
conductive hearing loss to inflammatory rheumatoid joint diseases and questioned 
whether the sensorineural losses were due to ototoxic effects from salicylates.   
Results of more recent studies in which the researchers controlled for 
participants’ otologic history and the use of ototoxic medications have continued to 
find all types of hearing loss in the RA populations.  General findings across studies 
have reported a higher percentage of hearing loss compared to age and gender 
matched controls (Özcan et al., 2002; Raut et al., 2001; Salvinelli et al., 2004; 
Salvinelli et al., 2006).  However, no differences between specific audiometric 
measurements in RA and age and gender matched controls have also been reported 
(Halligan, Bauch, Brey, Achenbach, Bamlet, McDonald, & Matteson, 2006).  The 
hearing loss is typically bilateral, although unilateral hearing loss has also been 
observed, and both unilateral and bilateral hearing losses are typically mild to 
moderate in degree (Özcan et al., 2002; Raut et al., 2001).   
Several studies have reported all types of hearing loss among their samples of 
patients with RA.  Özcan et al. (2002) and Raut et al. (2001) examined the hearing 
sensitivity in individuals with RA (35-38 participants) and found sensorineural 
hearing loss in 26-60%, conductive hearing loss in 17-26%, and mixed hearing loss in 
10-47% of the study participants.  A higher prevalence of conductive involvement 




result of the different criteria used to classify the presence of a conductive component 
[air-bone gap greater than 5 dB (Özcan et al., 2002) versus air-bone gap greater than 
20 dB (Raut et al., 2001)].   
Similarly, Salvinelli et al. (2004) reported that in the RA group, 10/38 had 
sensorineural hearing loss, 21/38 mixed hearing loss and 7/38 had a conductive 
hearing loss. These results indicated that every individual in the RA group had 
hearing loss.  The authors stated that most individuals had an air-bone gap, but did 
not state what they considered to be a significant air-bone gap.  They reported most of 
the participants with RA (28/38) had conductive involvement, but the limited details 
regarding criteria to define hearing loss make comparisons with other studies 
difficult.  A more recent study by this group of authors also reported a higher 
prevalence of hearing loss in the RA group compared to an age- and gender- 
comparable NC group (Salvinelli et al., 2006).  Criteria for a significant air-bone gap 
were not defined, and a wide variety of hearing loss types were reported.  Twenty-
four of the 28 participants with RA had hearing loss, and of these hearing losses 10 
were sensorineural, eight were mixed, and six were conductive.  Salvinelli et al. 
(2006) reported exclusion criteria based on a significant otologic history; however, 
due to the presence of air-bone gaps, four of the individuals with RA underwent 
stapedectomy surgery.  The researchers reported a closure of the mean air-bone gap, 
which changed from 11 dB HL pre-operatively to 2 dB HL post-operatively in these 
individuals.  Across studies, air- and bone-conduction thresholds were poorer in the 
RA populations compared to the control groups (Özcan et al., 2002; Salvinelli et al., 




conduction thresholds (500-2000 Hz) (Raut et al., 2001; Salvinelli et al., 2004), and in 
bone conduction thresholds at all test frequencies (250-4000 Hz) (Özcan et al., 2002; 
Salvinelli et al., 2004).   
In comparison to those studies that found a variety of hearing loss types, some 
studies have found a higher incidence of only sensorineural hearing loss in RA 
populations (Goodwill et al., 1971 & 1972; Kastanioudakis et al, 1995; Magaro et al., 
1990).  Based on pure-tone audiometric results, several researchers reported that 44-
55% of the individuals with RA tested had sensorineural hearing loss (Kastanioudakis 
et al, 1995; Magaro et al., 1990). The pure-tone results indicated that these 
individuals had bilateral hearing loss of mild degree.  However, Magaro et al. (1990) 
included only participants with normal Type A tympanograms, which may account 
for the lack of conductive-type hearing impairments.  In addition, the high prevalence 
of hearing loss reported by Kastanioudakis et al. (1995) may be attributed to 
presbyacusis and not to RA.  The authors defined hearing loss as hearing thresholds 
greater than 20 dB HL at two or more frequencies without accounting for potential 
effects of aging, despite the fact that 14 of their 45 participants were over 60 years 
old. 
Still other studies have also indicated a high prevalence of both sensorineural 
hearing loss and abnormal middle ear function in individuals with RA (Elwany et al., 
1986; Reiter et al., 1980; Takatsu et al., 2005).  The results reported by Elwany et al. 
(1986) and Takatsu et al. (2005) indicated that approximately one-third of the 
individuals with RA tested had sensorineural hearing loss, and that many of the 




stiffness of the middle ear system (Elwany et al., 1986; Kakani et al., 1990; Takatsu 
et al., 2005).  However, the individuals with abnormal tympanograms did not 
necessarily have sensorineural hearing loss.  The hearing loss in individuals with RA 
was generally a mild bilateral loss.  Significant threshold differences were noted 
between individuals with RA and controls in the lower and mid frequencies, 250-
2000 Hz, and at 4000 Hz (Takatsu et al., 2005).  This finding is similar to the results 
of Raut et al. (2001) and Öztürk et al. (2004), who also reported significant changes 
in the higher-frequency regions.  Takatsu et al. (2005) found a significant difference 
in air-bone gaps at 250 and 500 Hz between groups without reporting any conductive 
hearing loss, but the criteria for a conductive component used in the study was an air-
bone gap greater than 20 dB at two or more frequencies.  Therefore, these stringent 
criteria may account for the lack of reported conductive involvement. The 
audiometric results reported by Reiter et al. (1980) were consistent with the higher 
prevalence of hearing loss reported by many other studies; in addition, almost 60% of 
individuals with RA had abnormal tympanograms with either an increase or decrease 
in stiffness.  The researchers also reported three instances of conductive hearing loss 
in the group of individuals with RA, which typically coincided with an increased 
laxity of the middle ear system.  Individuals with sensorineural hearing loss also had 
tympanograms that indicated an increase in the laxity of the middle ear system.  The 
high rate of middle ear abnormalities was believed to contribute to the increased rate 
of hearing loss in individuals with RA.  The high prevalence of hearing loss may 




but this involvement typically is not significant enough to result in a measurable 
conductive component (Takatsu et al., 2005).   
One study has also indicated an effect of RA on ultra-high frequency hearing 
sensitivity.  Öztürk et al. (2004) reported a higher rate of sensorineural hearing loss 
for individuals with RA at ultra high-frequency regions.  Ultra-high frequency 
thresholds were assessed up to 16,000 Hz in 74 participants with RA.  The 
researchers from this study reported higher thresholds in participants with RA across 
all frequencies compared to a group of 45 normal controls of the same age and gender 
distribution.  Most notably, ultra high-frequency sensorineural hearing loss was found 
in individuals with RA and the severity of ultra high-frequency hearing loss 
correlated with longer disease duration.    
Another study indicated differences in transient evoked otoacoustic emissions 
(TEOAEs) recorded in individuals with RA compared to an age and gender 
comparable NC group (Salvinelli et al., 2006).  Salvinelli et al. (2006) reported 
decreased reproducibility and amplitude of TEOAEs in the RA group compared to the 
NC group.  However, 14/28 of the individuals in the RA group had a conductive 
component that would affect the measurement of TEOAEs, making it difficult to 
determine whether the differences were due to middle ear abnormalities or outer hair 
cell function in the inner ear. 
Evidence in the literature points toward a trend for greater auditory 
involvement among those individuals with more advanced disease involvement.  
Fluctuating sensorineural hearing loss associated with disease severity and “flare-




Larouere, 1997; Nores & Bonfils, 1988).  In the study conducted by Özcan et al. 
(2002), the participants were grouped according to disease stage using the 
Steinbrocker functional classification index (Steinbrocker, Traeger, & Batterman, 
1949).  A higher incidence of hearing loss was found among participants with RA 
that had greater disease severity.  A higher prevalence of sensorineural hearing loss in 
individuals with RA was found in those who had nodules compared to those without 
nodules (Goodwill et al., 1971 & 1972; Takatsu et al., 2005). Magaro et al. (1990) 
found that the presence of sensorineural hearing loss significantly correlated with 
active RA compared to an inactive disease stage. They also found a significant 
correlation between individuals who had tested positive for rheumatoid factor and 
poorer hearing thresholds.  Salvinelli et al. (2006) reported a significant inverse 
correlation between disease duration and TEOAE amplitude. Takatsu et al. (2005) 
classified the RA groups according to disease severity and staging, and found a 
significant difference in ESR rates between individuals with RA and hearing loss, 
compared to individuals with RA and no hearing loss.  This finding suggested that 
individuals with high levels of inflammation might be more likely to have auditory 
involvement.  However, this issue is also debated among researchers, similar to many 
other aspects involving auditory function and RA.  Other studies have reported 
finding no influence of RA disease activity or duration on hearing loss (Goodwill et 
al., 1971 & 1972; Kakani et al., 1990).  It should be noted that in the report by 
Takatsu et al. (2005) the value of inflammation levels as determined by ESR in 




extra-articular manifestations such as nodules, indicating that many of the individuals 
did not have severe disease manifestations. 
Ototoxicity has been cited as another potential cause of hearing loss in 
patients with RA.  While there are numerous pharmacological treatment options for 
RA, the research addressing ototoxicity has been quite limited.  Researchers have 
acknowledged the common use of potentially ototoxic medications such as salicylates 
and loop diuretics for treatment of RA (Goodwill et al., 1971 & 1972; Heyworth & 
Liyanage, 1972; Mukerji, Esterm & O’Sullivan, 1994).  As would be expected, when 
individuals with RA discontinued the use of salicylates, hearing sensitivity returned to 
normal limits, indicating only temporary ototoxic effects (Heyworth & Liyanage, 
1972).  No significant differences were found between individuals with RA who had 
previously taken salicylates and those who had not (Goodwill et al., 1971), suggesting 
only current use of salicylates might potentially affect hearing sensitivity. 
More recent pharmacological treatment of RA often involves nonsteroidal 
anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs 
(DMARDs) (Moreland, 2004; U.S. Department of Health and Human Services: 
NIAMS, 2004).  While studies have cited the possible influence of ototoxicity on 
hearing loss in individuals with RA, it has been difficult to separate and identify the 
various potential causes of hearing loss.  Little evidence exists regarding the effects of 
potentially ototoxic medications used to treat this population.  A single study, 
Kastanioudakis et al. (1995), found no correlation between sensorineural hearing loss 
and the common antirheumatic medications NSAIDs, D-penicillamine, plaquenil and 




long-term use, RA medications have also been used to treat and restore sudden 
hearing loss in individuals without RA or inflammations. The use of several RA 
medications such as prednisone (Haberkamp & Tanyeri, 1999) and more recently 
TNF inhibitors and methotrexate may help restore and improve hearing in individuals 
with autoimmune inner-ear disease that experienced a sudden hearing loss (Street, 
Jobanputra, & Proops, 2006). 
RA and Middle Ear Function  
 
Researchers have reported a high prevalence of abnormal middle ear function 
in individuals with RA, but the effects on middle ear function have varied (Elwany et 
al., 1986; Öztürk et al., 2004; Takatsu et al., 2005).  Abnormalities reported in the 
literature on this topic have included an increased stiffness of the middle ear system 
(Biasi et al., 1996; Colletti et al., 1997; Elwany et al., 1986; Öztürk et al., 2004; 
Takatsu et al., 2005) as well as increased laxity of the middle ear system (Moffat et 
al., 1977; Rosenberg et al., 1978).  The presence of abnormal middle ear systems has 
not consistently correlated with effects on hearing thresholds in individuals with RA.  
Generally, individuals with conductive hearing loss have an increase in the laxity of 
the middle ear system, although a clinically significant conductive hearing loss is rare 
in this group (Raut et al., 2001).  The majority of studies suggest the most common 
effect is increased stiffening of the middle ear system that may not necessarily 
coincide with hearing loss (Elwany et al., 1986; Öztürk et al., 2004). 
Several reports of visual inspection of the middle ear space through surgical 
intervention and temporal bone autopsy have provided compelling evidence of 




1977).  In a case study of a man with RA undergoing surgery for a unilateral 
conductive hearing loss, Goodwill et al. (1972) noted that the ossicular chain was 
intact and there were no visible signs that would cause a conductive hearing loss.  
Due to the normal appearance of the middle ear system, the authors theorized the 
probable cause of the conductive hearing loss was rheumatic involvement.  Atypical 
lesions of the incudomalleal and incudostapedial joints were found in a woman with 
long-standing RA and sicca syndrome (Sjögren Syndrome) (Gussen, 1977).  In a case 
study of this 55-year old woman, a temporal bone autopsy revealed striking changes 
in the ossicular joints.  The incudomalleal and incudostapedial joints exhibited 
dissolution of disk material and proliferation of synovial-type elements in the 
articulations, forming pannus tissue.  Unfortunately, audiometric data were only 
obtained when the woman was 37 and 42 years of age.  At the time of audiometric 
evaluation, a slight bilateral high-frequency hearing loss was present and no further 
mention of hearing loss was noted in the records.   
Standard tympanometric measurements have been used to identify abnormal 
middle ear systems in individuals with RA, frequently using low-frequency 
tympanometry analyzed according to the Jerger tympanometric classification system 
(Jerger, 1970).  Several studies suggested an increased stiffness of the middle ear 
system in individuals with RA, resulting in tympanograms classified as Type As 
(Elwany et al., 1986; Öztürk et al., 2004; Takatsu et al., 2005).  Specifically, the 
researchers reported that about 28% of individuals with RA (Takatsu et al., 2005) and 
52-58% of the ears in individuals with RA were classified as having Type As 




provided the static admittance values used to define what classified a Type As 
tympanogram (≤ 0.3 ml), Öztürk et al. (2004) and Elwany et al. (1986) did not use 
quantitative criteria to determine tympanogram classification.  When quantitative 
values were reported by Öztürk et al. (2004), the ranges listed for the RA group 
closely approximated normal static admittance ranges.  They reported more than half 
of the ears in the RA group had type As, tympanograms, and that 10.8% and 13.5% of 
left and right ears, respectively, had type Ad tympanograms, but the static admittance 
ranged from 0.28-1.6 mL in this group of participants.  This range is similar to the 
range of normal admittance (0.3-1.7 mL) as determined by Margolis and Goycoolea 
(1993).  The values used to determine the criteria for tympanogram typing were not 
specified in some studies, which make it difficult to compare the results based on the 
researcher’s tympanogram type classification.  Despite these limitations, however, 
Öztürk et al. (2004) reported the RA group had significantly lower admittance values 
than a group of age and gender comparable NC participants.  Elwany et al. (1986) 
reported that over 70% of the 68 patients with RA had static admittance levels that 
were reduced to one-half or one-third of normal admittance values; however, the 
listed compliance ranges were essentially within normal limits (0.29-0.72 cc).  
Although a high prevalence of sensorineural hearing loss was present in the RA 
participants, no correlation was found between reduced middle ear admittance and 
sensorineural hearing loss (Elwany et al., 1986).   
Two studies that used multifrequency tympanometry to examine middle ear 
function in individuals with RA have also reported an abnormally stiff middle ear 




40% of the 30 participants with RA had abnormal middle ear resonant frequencies 
compared to the control group.  Higher resonant frequencies indicated an increased 
stiffness was the most common type of abnormality, although some cases of an 
increased laxity were also recorded as indicated by lower resonant frequency (Biasi et 
al., 1996; Colletti et al., 1997).  Both studies only included individuals with inactive 
disease staging, which may account for the lack of observed hearing loss.  Frade and 
Martin (1998) assessed middle ear function using multifrequency tympanometry, but 
did not find significant differences between individuals with RA compared to 
normative data.  However, a difference was observed when comparing individuals 
with active versus inactive disease activity.  Individuals with active RA had stiffer 
middle ear systems indicated by a higher resonant frequency than those individuals 
with inactive RA, and due to these differences, the authors suggested multi-frequency 
testing might help to diagnostically determine disease activity.   
The trend of increased middle ear stiffness was also observed in children with 
chronic juvenile RA (Giannini, Marciano, Strano, Alessio, Marcelli, & Auletta, 1997; 
Siamopoulou-Mavridou, Asimakopoulos, Mavridis, Skevas, & Moutsopoulos; 1990).  
More than half (10/18) of the children (aged 6-16 years) with juvenile RA in the 
study conducted by Siamopoulou-Mavridou et al. (1990) had abnormally stiff Type 
As tympanograms, although no audiometric data were collected to determine a 
potential correlation with hearing loss.  This study performed few measurements, 
testing only 220-Hz tympanograms and acoustic reflexes in the 18 children with 
juvenile RA and a control group of 14 gender and age matched children.  




The authors interpreted these findings to indicate a stiffening of the middle ear system 
as a result of inflammation of the ossicular joints, and found this most often occurred 
in patients with the most severe symptoms.  Giannini et al. (1997) reported children 
with chronic juvenile RA (M = 9.9, SD = 5.2 years) presented with higher middle ear 
resonant frequencies compared to a control group of 30 healthy children (M =7.7, SD 
= 3.6 years; Giannini et al., 1997).  Of interest, all 35 children with RA exhibited 
normal audiometric thresholds (less than 25 dB HL), normal 226-Hz tympanograms 
and normal acoustic reflexes.  While the increased stiffness of the middle ear system 
was not detected by low-frequency tympanometry, it was identified through the use 
of multi-frequency tympanometry.  
Although the majority of studies examining middle ear function in patients 
with RA have indicated increased stiffness of the middle ear system, several 
researchers have reported tympanometric data that indicated patients with RA had an 
increased laxity of the middle ear system (Moffat et al., 1977; Rosenberg et al., 
1978).  Two studies examined middle ear function by using a 660-Hz tympanometry 
and found 38-42% of individuals with RA exhibited a marked notch in the 
tympanogram (Moffat et al., 1977; Rosenberg et al., 1978).  This finding suggested an 
abnormally low resonant frequency and, thus, an increased laxity of the middle ear 
system and/or mass changes in the participants with RA compared to normal controls.  
While Moffat et al. (1977) did not assess pure-tone thresholds, the audiometric results 
from Rosenberg et al. (1978) suggested no significant hearing loss in individuals with 
RA despite the presence of middle ear abnormalities.  Raut et al. (2001) compared the 




however, no statistically significant differences between groups were observed.  
These authors also measured middle ear function with a 226-tympanogram analyzed 
according to Jerger’s classification system (Jerger, 1970). The results from Raut et al. 
(2001) revealed that 25.71% (11 ears from 9 individuals) of tested ears in the RA 
group had high compliance classified as Type Ad and these researchers reported no 
cases of an increased stiffness of the middle ear system.  Although no individuals in 
the control group exhibited Type Ad tympanograms, the average admittance for the 
group of individuals with RA and for the control group were not significantly 
different.  The authors suggested that the conductive hearing loss documented in the 
participants with RA (6/35) was most likely due to a laxity of the middle ear system.  
However, the most common type of hearing loss recorded by these authors was a 
sensorineural hearing loss found in 21 individuals in the RA group.         
Other researchers have reported both increased stiffness and laxity of the 
middle ear system in a group of individuals with RA.  Reiter et al. (1980) used 660-
Hz susceptance tympanograms and converging susceptance patterns for 220- and 
660-Hz probe tones to assess middle ear function.  Immittance data revealed that 
almost 60% of the arthritic ears (27 of 46) exhibited abnormal findings; 22% (10 ears) 
showed an increased laxity from a 660-Hz notched tympanogram, and 37% (17 ears) 
showed an increased stiffness from a negative-pressure convergence of susceptance 
function.  The RA group in this study had a high rate of hearing loss, 48% (11 
individuals) with sensorineural hearing loss and 13% (three individuals) with 
conductive hearing loss.  Two of the individuals with conductive hearing loss had a 




increase in the effective mass of the system caused by damage to the ligaments that 
anchor the ossicles.  A high rate of sensorineural hearing loss and abnormal middle 
ear function was also found.   
A variety of abnormal tympanometric results were also found by Özcan et al. 
(2002).  The authors reported almost 40% of the 37 participants with RA tested had 
abnormal tympanograms, according to Jerger’s classification system (Jerger, 1970).  
These abnormal tympanometric results were dispersed across individuals with normal 
hearing, as well as sensorineural, conductive, and mixed hearing loss. Tympanograms 
were abnormal in 38% (14/35) of the individuals in the RA group, affecting 23 ears.  
The tympanograms recorded included: 13 type As, 8 type Ad, and 2 type B.  The 
authors suggested a discontinuity of the ossicles was responsible for the conductive 
hearing loss.  The abnormally stiff middle ear systems did not result in a measured 
conductive hearing loss, but were recorded in some individuals in the RA group with 
sensorineural hearing loss, as well as individuals with no measured hearing loss. 
 Despite the varied results in studies assessing middle ear function in 
individuals with RA, trends across the literature suggest some involvement of the 
middle ear system in individuals with RA.  The findings of middle ear abnormalities 
suggest possible inflammation of the synovial ossicular joints located in the middle 
ear, causing an increase stiffness or laxity of the tympano-ossicular system (Giannini 
et al., 1997; Raut et al., 2001).  The rheumatic involvement of the ossicular joint 
ligaments and capsules may explain both the stiffness and laxity of the middle ear 
system, depending on how the inflammation affects the joints.  Another potential 




affected by vasculitis (Biasi et al., 1996; Camilleri, 1991; Goodwill et al., 1972; Raut 
et al., 2001; Reiter et al., 1980).  This may result in ankylosis or decreased mobility of 
one or both ossicular joints.  There was a high prevalence of middle ear abnormalities 
that did not coincide with conductive hearing loss, but rather coincided with 
sensorineural hearing loss (Reiter et al., 1980; Takatsu et al., 2005).  It has been 
hypothesized these abnormalities may reduce the protective mechanism of the middle 
ear and subsequently result in cochlear damage (Colletti et al., 1997; Öztürk et al., 
2004; Raut et al., 2001).  The altered motion of the ossicular diathroses reduces the 
movements of the ossicles and could lead to gradual hair cell damage over time, and 
possibly make the inner ear more susceptible to potential oto-traumatic agents (Biasi 
et al., 1996; Colletti et al., 1997).  This theory would help to explain the high 
prevalence of sensorineural hearing loss and middle ear abnormalities observed in 
individuals with RA. 
Summary and Purpose: 
 
Existing literature indicates an increased prevalence of hearing loss in 
individuals with RA, including conductive, sensorineural, and mixed hearing losses.  
The most common type of hearing loss is sensorineural that often coexists with 
abnormal middle ear function (e.g., Takatsu et al., 2005).  There remains much debate 
and speculation about the involvement of the middle ear system and the cause of 
hearing loss in this population.  In part, limited measurements have been used to 
assess middle ear function in individuals with RA.  Middle ear measurements have 
typically consisted of standard 226-Hz tympanograms that were analyzed based on 




limited measurements, which have particular inadequacies for pathologies that affect 
the ossicular chain, may help to explain the wide variety of results in RA research.  A 
few studies have examined multi-frequency tympanometry, and one set of researchers 
was able to identify changes in stiffness not detected by low-frequency tympanometry 
(Giannini et al., 1997).  The ability to test a broader range of frequencies, as with 
multi-frequency tympanometry and ER measurements, shows promise for detecting 



















Chapter 3: Research Questions and Hypothesis 
 
The goals of this study are to provide a comprehensive examination of 
auditory function in individuals with RA, specifically focusing on the effects of RA 
on sound transmission through the middle ear using multi-frequency tympanometry 
and ER.  The majority of the existing research on this topic has focused primarily on 
RA and the presence of hearing loss, thereby assessing auditory function through the 
use of pure-tone audiometry and basic tympanometry.  This study aims to broaden the 
scope of auditory assessment and focus on the evaluation of middle ear function.   
The specific questions addressed by this study include the following: 
1. Is there a difference in the prevalence of hearing loss in individuals with RA 
compared to age- and gender-matched controls? If hearing loss is present, are 
there qualitative differences in the type of hearing loss between groups? 
2. Are there differences in audiometric thresholds between individuals with RA 
compared to age- and gender-matched controls?  
3. Do audiometric thresholds in both groups fall within the range of expected 
effects of aging on hearing thresholds? 
4. Is there a difference between individuals with RA compared to age- and 
gender-matched controls on the following immittance-based measures of 
middle ear function:  
a. Static admittance and tympanometric peak pressure for 226-Hz 
tympanograms 
b. Qualitative shape classifications of 678- and 1000-Hz tympanograms 




d. Middle ear resonant frequency 
5. Is there a difference between individuals with RA compared to age- and 
gender-matched controls on measures of ER? 
6. Is there a difference in DPOAE amplitude levels between individuals with RA 
compared to age- and gender-matched controls? 
7. Does varying level of disease involvement in individuals in the RA group 
correlate with audiologic measures? 
It was hypothesized that the RA group would have poorer auditory thresholds 
and a higher prevalence of hearing loss compared to the control group and that the 
type of hearing loss would primarily be sensorineural.  It was expected middle ear 
measurements would reveal a difference between groups, with a greater number of 
abnormal findings in the RA group compared to existing normative data.  However, 
the types of middle ear abnormalities were expected to include both an increased 
stiffness and laxity.  It was expected that 226-Hz tympanometry would not reveal 
differences between groups; however, due to the broader frequency range assessed by 
ER, it was hypothesized this measure would reveal significant differences.  Multi-
frequency tympanometry was expected to reveal some differences between groups 
because it has been demonstrated to be more sensitive to middle ear abnormalities 
than 226-Hz tympanograms, but it was anticipated ER would provide new 
information about the differences between groups because of the larger frequency 
range assessed.  It was hypothesized that individuals with higher levels of 
inflammation and a greater number of involved joints would have more middle ear 




was anticipated that multi-frequency tympanometry and ER would help clarify the 
debate surrounding hearing loss and middle ear involvement in individuals with RA 
by contributing more information about sound transmission through the middle ear in 
these individuals.  These findings could provide insight into the manifestations of this 
disease in the auditory system as well as the need for inclusion of audiometric 




Chapter 4: Methods 
Participants 
This is a cross-sectional study examining the audiological differences between 
two groups: an experimental group of individuals with RA and a control group of 
age- and gender-matched healthy adults without RA.  Twenty-one participants (38 
ears) from each group were included in the study.  Participants were excluded based 
on the following criteria: significant history of outer or middle ear pathology (e.g., 
chronic ear infections) or surgery (e.g., repair of ear drum perforations), head trauma 
or brain injury, noise exposure, and use of ototoxic medications (e.g., salicylates).  
Participants were also required to have normal otoscopic examination indicating an 
ear canal free from excessive cerumen or debris and without visible signs of 
excessive scarring on the eardrum.  Excessive tympanic membrane scarring was 
defined as the presence of white patches or scar tissue, consistent with 
tympanosclerosis, as determined by otoscopic inspection performed by the examiner.  
The same individual performed all otoscopic determinations.  
Initially, 25 participants with RA and 23 participants serving as NCs were 
tested.  Four individuals with RA and two individuals from the NC group were 
excluded based on a significant otologic history (pressure equalization tubes; 
Eustachian tube dysfunction; tympanic membrane perforation), significant history of 
noise exposure, head/brain injury (stroke), and/or diagnosis of another type of disease 
(Psoriatic arthritis) and not rheumatoid arthritis.  In addition, three participants had 
one ear excluded based on otoscopic examination revealing scarring on the tympanic 




given the option to complete the hearing evaluation.  Participants were fully informed 
of all procedures before testing. A sample Consent Form is shown in Appendix A.  
All participants completed a General Health Questionnaire, which is shown in 
Appendix B.  All individuals in the NC group reported a negative history for any 
signs or symptoms consistent with RA, as identified by patient responses to the 
General Health Questionnaire. 
The RA group, consisting of 21 participants, ranged in age from 24-64 years 
old with an average age of 51.10 years, and a standard deviation of 11.52 years.  The 
control group was matched 1:1 based on age (±1 year) and gender with RA 
participants.  The normal control (NC) group, consisting of 21 participants, ranged in 
age from 25-63 years old with an average age of 51.14 years, and a standard deviation 
of 11.30 years.  Age did not differ significantly between groups (t = 0.01; p = 0.99). 
The experimental group included adults with RA diagnosed by a physician 
according to the 1987 American College of Rheumatology classification criteria 
(Arnett et al., 1988).  The RA group was recruited from a natural history study on RA 
conducted by Dr. Raphaela Goldbach-Mansky at the National Institute of Arthritis 
and Musculoskeletal and Skin Diseases (NIAMS) at the National Institutes of Health 
(NIH) in Bethesda, Maryland.  The NC group reported a negative history for RA or 
symptoms similar to RA.  The NC group was recruited by flyers and word of mouth.   
Otologic history for both groups was obtained through a questionnaire and 
self-reporting.  The medical history for the NC group was obtained through 
questionnaires and self-report by participants.  The medical charts of RA participants 




test results for inflammation levels documented by ESR and CRP levels.  
Demographic and disease information for RA participants is listed in Table 1.   
No participants were currently taking salicylates for treatment of RA.  Based 
on blood test results, ESR rates greater than or equal to 25 mm/hr and CRP and high-
sensitivity CRP levels greater than 0.80 mg were considered abnormally high and 
indicative of high inflammation levels.  The blood test results from the RA group 
were obtained within one week of audiological testing for 18 of the participants, of 
which 12 were obtained on the same day, and two within three weeks.  One patient 
with longstanding RA (22 years) failed to have blood work completed on the date of 
audiological testing, but the patient was seen for her physician’s exam.  In this 
instance, the patient was classified with inactive disease staging by her physician, and 
blood work from approximately three months prior to audiological testing and 
approximately three months following audiological testing were compared.  These 
results were consistent with stable disease activity.  The ESR level was 12 mm/hr pre-
audiological assessment, compared to 13 mm/hr in a subsequent assessment 
following audiological evaluation, and CRP was 0.71 compared to 0.74 mg/dL, 
respectively.  All values are consistent with normal levels and inactive disease 
staging.  In this instance, the blood test results from 3 months prior were used because 
they were obtained closest to the date of assessment.  Active versus inactive staging 
classification was not consistently identified by physicians for all participants; and, 
therefore could not be further discussed. 
The average disease duration of individuals with RA was 13.67 years (SD = 





Demographic and Disease Information for RA Participants 
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59-F 12 0.71 + 81 3 22 X X X
59-F 40(+) 0.46 + 0 14
 





0.24 + 0 3 30 X X X
60-M 5 0.53 + 4 8 24 X X X
61-F 23 0.23 + 6 0 37 X X
62-F 11 0.23 + 0 0 4 X
* 63-F 37(+) 0.78 + 7 2 15 X X
** 64-M 62(+) 0.33 + 0 0 18 X X
Range 24-64 5-62 <0.4-2.08 0.53-1.30 0-81 0-22      4-37
Mean 51.10    23.10 0.82 0.50 6.81 6.62      
      
13.67




Note.  Demographic and disease information for Table 1 was obtained from review of medical charts and blood work 
results.  Positive results for signs of inflammation were designated with a (+).  Erythrosedimentation rates (ESRs) were 
considered positive for values greater than or equal to 25 mm/hr; C-reactive protein (CRP) and high-sensitivity CRP (high 
sens. CRP) were considered positive for values greater than 0.80 mg/dL.  The blood work column represents the number of 
days between the date of blood work and the date of audiological assessment. The number of swollen joints was obtained 
from physicians’ examination notes.  Individuals diagnosed with Sjögren’s syndrome are designated by one asterisk (*), 
and individuals diagnosed with diabetes are designated by two asterisks (**) located next to the first column.  The use of 
current medications such as non-steroidal anti-inflammatory drugs (NSAID), disease modifying antirheumatic drugs 




the 21 participants (81%) had tested positive for rheumatoid factor in their medical 
history.  Three individuals were also diagnosed with Sjögren’s syndrome, which is an 
autoimmune disease that destroys moisture-producing glands, and is often associated 
with rheumatoid arthritis.  Three other individuals presented with type II diabetes, 
although none were taking insulin, and none of these individuals’ test results revealed 
hearing loss.  
Not all of the 21 participants in each group could be included in the analyses 
of acoustic reflexes, ER and DPOAEs.  Acoustic reflex thresholds (ARTs) were 
measurable in 35/38 ears from the RA group, and 37/38 ears from the NC group.  
ARTs could not be obtained in three ears in the RA group and one ear in the normal 
control group due to fluctuating static admittance.  In addition, another normal control 
ear had absent reflexes at two frequencies in one contralateral test condition that were 
unexplained by the presence of a conductive component or degree of hearing loss.  
Only ears with measurable ARTs were included in this analysis, and the matched 
participants of the same age and gender from the opposite group were excluded.  As a 
result, 33 ears from 19 participants in each group were included in the analysis of 
ARTs. 
Only that subset of individuals who had tympanometric peak pressure 
between –10 and +10 daPa of ambient pressure as determined by 226-Hz 
tympanometry were included in ER and DPOAE data analysis.  The test equipment, 
manufactured by Mimosa, tests at ambient pressure, requiring the exclusion of those 
participants whose tympanometric peak pressure fell outside the –10 to +10 daPa 




and were matched 1:1 based on age and gender.  Table 2 displays the number of 
participants and ears that were included in analysis for each measurement. 
Procedures 
 
Testing took place in two locations: the Audiology Department in the Clinical 
Center at the National Institute on Deafness and Other Communication Disorders 
(NIDCD), National Institutes of Health (NIH) in Bethesda, Maryland and at the 
Hearing and Speech Clinic and research laboratories, Lefrak Hall, at the University of 
Maryland College Park.  All testing was completed during a single session 
approximately 1 to 1.5 hours in duration, with the participants seated in a sound 
booth.   
 The data collection consisted of audiometric measures, standard immittance 
measures, multi-frequency tympanometry, ER, and DPOAE measures.  The test order 
was consistent for all participants. Both ears were tested on all participants, and the 
ear tested first was randomized.  Case history and questionnaires were completed 
first, followed by otosopy, 226-Hz tympanometry, acoustic reflex thresholds and 
adaptation, 678-Hz and 1000-Hz tympanograms, and middle ear resonant frequency.  
After immittance measurements, SRT and air- and bone conduction thresholds were 
obtained, followed by word recognition.  ER and DPOAE measurements were 
obtained last.   
The audiometric measures, standard immittance and multi-frequency 
tympanometry were collected using GSI-61 audiometers and GSI-33 middle ear 
analyzers that were calibrated to American National Standards Institute (ANSI) 








Number of participants and ears from each group included in measurements 
 
Measurement Number of Participants 
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equipment was used in both locations for these measures.  Additionally, daily 
calibration of the GSI-33 Middle Ear Analyzers was conducted using the 
manufacturer supplied test cavity.  Data collected for ER and DPOAE measures were 
obtained using the same piece of equipment transported between locations.  
Calibration of the Mimosa ER and DPOAE system was conducted before testing each 
participant using the manufacturer supplied test cavity.   
Audiometric Measures 
Pure-tone audiometric testing was performed in a sound-treated booth using a 
standard diagnostic audiometer (Grason-Stadler, GSI-61).  Pure-tone air-conduction 
(AC) thresholds were established using insert earphones (Ear Tone ER-3A) in each 
ear at 250, 500, 750, 1000, 1500, 2000, 3000, 4000, 6000, and 8000 Hz.  Masked 
pure-tone bone-conduction (BC) thresholds were measured at 500, 1000, 2000, and 
4000 Hz.  Due to the disparity across previous studies regarding the definition of 
hearing loss, prevalence of hearing loss was determined using three criteria.  Hearing 
loss was defined as the presence of hearing thresholds at two or more frequencies in 
the tested ear at several thresholds levels: (1) greater than 15 dB HL, (2) greater than 
20 dB HL, or (3) greater than 25 dB HL.  A conductive component was defined as the 
presence of an air-bone gap of greater than 10 dB HL at two or more frequencies in 
the tested ear.  Hearing loss degree was categorized using the following criteria: mild 
at 26 to 40 dB HL; moderate at 41 to 55 dB HL; moderately-severe at 56 to 70 dB 
HL; severe at 71 to 90 dB HL; and profound at > 90 dB HL (Clarke, 1981).  When 
the cutoff for the presence of hearing loss was 15 or 20 dB HL, an additional category 




was 15 dB HL and a range of 21-25 dB HL when the criterion was 20 dB HL. The 
speech recognition threshold (SRT) was measured using spondees presented via 
monitored live voice.  The SRT was compared to the 3-frequency pure-tone average 
obtained at 500, 1000, and 2000 Hz in order to verify validity of audiometric results.  
Word recognition scores were measured as percent correct using Northwestern 
University-6 (NU6) word lists.  The 25 word-lists were presented using monitored 
live voice at 40 dB SL re: SRT.  Word recognition scores were obtained following 
standard clinical procedures conducted at the NIH and completed to provide 
participants with a comprehensive audiological evaluation.  This measure was not 
examined in data analyses.  
Standard Immittance 
 
 Standard immittance measurements were obtained using the Grason Stadler 
(GSI-33) middle-ear analyzer.  Single-frequency admittance tympanograms were 
measured using a 226-Hz probe tone to obtain tympanic peak pressure (TPP), ear 
canal volume, and peak-compensated static admittance.  Tympanometry was 
considered normal if the static admittance value was between 0.3-1.7 mmhos 
(Margolis & Goycoolea, 1993) and if the TPP was between +50 to –150 daPa.  The 
TPP criteria used were a conservative measure in comparison to the Jerger 
tympanometric classification system, which classifies negative pressure at -200 daPa 
(Jerger, 1970).  Tympanometric width was considered normal between 50-115 daPa 
(Margolis & Heller, 1987).  The TPP obtained from the 226 tympanogram was used 
as a selection criterion such that only individuals with TPP ±10 daPa were included in 




measurements assisted in confirming otoscopic findings by verifying an intact 
tympanic membrane and an unoccluded ear canal.   
Acoustic reflex thresholds were determined at 500, 1000, and 2000 Hz in the 
ipsilateral and contralateral stimulus conditions. Acoustic reflex adaptation was 
evaluated in the contralateral condition using a 10 second tonal presentation at 500 
and 1000 Hz at a level 10 dB above the acoustic reflex thresholds.  Presentation levels 
did not exceed 110 dB HL for either of these tests.  Acoustic reflex threshold testing 
assesses the function of the middle ear system, the inner ear, and the auditory neural 
pathway by measuring a reflexive contraction of the stapedius muscle in the middle 
ear in response to loud sounds.  Acoustic reflex adaptation was assessed to 
differentiate a cochlear hearing loss from a retrocochlear hearing loss should a 
participant present with a sensorineural hearing loss. 
Multi-frequency Tympanometry 
 
  Additional single frequency tympanograms were obtained using 678- and 
1000-Hz probe tones.  Susceptance (B) and conductance (G) tympanograms were 
obtained to provide information about the mass and compliance of the middle ear 
system.  The shape of the tympanograms was evaluated using the Vanhuyse et al. 
(1975) model.  Notching (“W”) of the tympanograms occurs when the middle ear 
system becomes mass controlled (Margolis et al., 1985).  The admittance at +200 
daPa and at the central maxima or minima were measured from the B and G 
tympanograms and compared between participant groups for the 678- and 1000-Hz 
tympanograms.  Using the formulae described by Calandruccio et al. (2006), the 




at the mid-point was calculated using Equation 2, where Y equals admittance, B 
equals susceptance, and G equals conductance in mmhos.  
 
Y+200 = √ (Btail2 + Gtail2)                                                                    (1) 
 
Ymidpt = √ [(Bmidpoint – Btail)2 + (Gmidpoint – Gtail)2]                    (2) 
 
Middle ear resonant frequency was also obtained using a sequential frequency 
sweep from 226-2000 Hz in 50 Hz increments.  The resonant frequency was 
automatically calculated by the GSI-33 Middle Ear Analyzer as the frequency where 
the difference in susceptance from the extreme positive canal pressure to the midpoint 
peak/dip was equal to 0 mmhos.  
ER and DPOAE Measures 
Equipment.  ER was measured using the commercially available Reflectance 
Measurement System (Mimosa Acoustics, Inc.) and Mimosa Acoustics RMS 3.1.8 
version software.  The Mimosa Acoustics Inc. wideband middle ear power analyzer 
(wbMEPA) plots the ER characteristics of sound transmission by the middle ear.  The 
system uses the four-cavity method of measurement developed by Allen (1985) and 
used by Keefe et al. (1992) and Voss and Allen (1994).  The instrumentation consists 
of a laptop computer (Dell Pentium laptop), a PC card (PCMCIA card) for digital 
signal processing, a DPOAE probe system (Etymotic Research ER-10C), an adaptor 
cable, and a four-cavity calibration device. The PC card is inserted into the computer, 




Calibration and Measurement.  Two separate calibration procedures were 
conducted prior to data collection from each participant: calibration in the cavity, and 
calibration of in-the-ear sound pressure.  The cavity calibration was made with the 
probe tip placed in a four-chambered test cavity provided by the manufacturer.  This 
test cavity was used to assess the pressure-frequency response by presenting a 1-sec 
chirp.  The Thevenin equivalent parameters were computed from the probe responses.  
A pass/fail criterion predetermined by the manufacturer calculates the tolerance range 
from these measures, based on Thevenin principles (Allen, 1985).  The measurements 
from the four-cavity calibration were used to create a frequency response that was 
used to obtain the transducer source pressure and source impedance.  The second type 
of calibration was the in situ calibration measurement.  This calibration measures the 
pressure-frequency response in the test ear by presenting a 1000 Hz tone at 60 dB 
SPL and helps to ensure an appropriate probe fit.  Both calibration methods were 
conducted immediately prior to data collection from each participant.  All 
measurements were conducted at ambient pressure; therefore, it was essential that 
participants have a  TPP ±10 daPa of ambient pressure.   
ER represents the proportion of the acoustic signal that is reflected back into 
the ear canal and is proportional to the amount of power absorbed by the middle ear: 
power absorption = 1 – ER (Feeney, 2005).  The Mimosa system represents ER as a 
percentage. 
ER was measured by presenting a chirp signal.  A foam tip was placed on the 
ER-10C probe.  Following calibration in the test cavity, the probe was inserted in the 




upon ear canal size and shape) as determined by visual confirmation that the lateral 
end of the foam tip was flush with the entrance to the external auditory meatus.  Once 
the probe fit had been confirmed by in situ ear canal pressure measurement, the chirps 
were presented at the default level of 60 dB SPL for a 2 sec duration.  The chirp level 
and duration were selected to ensure a sufficient signal-to-noise ratio and an accurate 
and repeatable response.  In accordance with previous reports (Feeney et al., 2003; 
Feeney & Sanford, 2004), ER measures were repeated three times per ear.  These 
three measurements were averaged at each test frequency to provide the final data set 
for each ear.  The system uses a sampling rate of 48,000 Hz and a maximum 
frequency range extending from approximately 200-6000 Hz.  Two-hundred-forty-
eight data points at approximately 20 Hz increments ranging from 211-6000 Hz are 
recorded and can be exported to a text file. 
The Mimosa Acoustic Inc. Hear ID 3.1.8 system was also used to obtain 2f1-
f2 DPOAE levels by recording a screening “DP-Gram.”  DPOAEs were measured 
using the same probe fit used for ER recordings.  The two stimulus tones were 
presented at 65 and 55 dB SPL, respectively.  The frequencies of the higher tone (f2) 
were 2000, 3000, 4000 Hz with the lower frequency tone (f1) set such that f2/f1 
equaled approximately 1.2.  A pass criteria were automatically generated by the 
system based on the following default settings:  DPOAE level was ≥ 10 dB SPL and 






Preliminary data were collected to ensure location differences and test order 
for tympanometry and ER did not affect test results.  
Location Differences. Preliminary data were collected to ensure that the test 
results were similar between locations, and that transporting the Mimosa Reflectance 
equipment did not affect measured results.  Additionally, these measures ensured that 
the test-retest reliability of the ER system was consistent with previous results 
(Hunter, 2004; Vander Werff & Prieve, 2004).  Data from a pilot group of five 
normal hearing young female adults without RA (aged 24-31) were collected to 
compare measurements obtained at each location.  All participants had the following 
tests conducted in both locations and the test order was the same in each location: 
otoscopy, standard immittance, multi-frequency tympanometry, SRT, air- and bone-
conduction thresholds, ER and DPOAEs.  This pilot study used the same pieces of 
equipment that were used throughout the study for data collection. These individuals 
did not have a significant history of middle ear pathology or surgery, noise exposure, 
or the use of ototoxic medications.  All individuals had hearing sensitivity less than or 
equal to 15 dB HL with no air-bone gaps > 5 dB present at audiometric test 
frequencies.  All individuals had TPP ±10 daPa as measured by 226-Hz 
tympanometry.  One individual had scarring bilaterally on the tympanic membrane as 
identified through routine otoscopy and another individual had absent contralateral 
reflexes and a history of head injuries.  The inclusion of these individuals was 
important to ensure the consistency of the equipment between locations for normal as 




The first ear tested was randomized.  All measurements for a given individual were 
conducted on the same day in both locations. ER measures were repeated three times 
with the same probe fit, and the mean was obtained and used as the final data set.  
Two sets of measurements with the probe removed and reinserted in between were 
obtained at each location to ensure the differences between locations did not vary 
more than expected test-re-test reliability from a different probe fit.   
Test Order.  In previous research, ER was measured after a 226-Hz 
tympanogram had been obtained (Feeney et al., 2003; Feeney & Sanford, 2004).  A 
preliminary study involving 10 adult females was conducted to assess whether test 
order impacts ER measurements and to ensure that the transient pressure 
manipulation in the ear canal during tympanometry did not alter ER results.  Inclusion 
criteria for this pilot study were a normal tympanogram with peak pressure ±10 daPa.  
One ear was randomly chosen from each participant.  Each participant had one ER 
measurement recorded, followed by a 226-Hz tympanogram, and then a subsequent 
ER measurement.   
Statistical Analysis 
 
Statistical analysis was performed using the Statistical Package for Social 
Sciences Software (SPSS), version 14.0 and Microsoft Excel.  Preliminary data 
compared location differences and test order differences.   Analyses of the differences 
between the RA and NC groups were performed using t-tests and two-way ANOVAs.  
Most ANOVA results violated Mauchley's test for sphericity.  In these cases, the 
Greenhouse-Geisser correction factor was applied for the degrees of freedom 




were bone-conduction thresholds in the preliminary data comparing locations, and 
DPOAE amplitudes in the results comparing RA and NC groups.  ER data were 
examined in one-third octave frequency intervals ranging from 250-6000 Hz.  
Previous studies reported ER results in one-third octave frequency intervals (Keefe et 
al., 1993, Voss & Allen, 1994).  Shahnaz and Bork (2006) reported that all significant 
findings observed when comparing 248 frequencies were replicated using one-third 
octave intervals. All tests were two-sided and p-values < 0.05 were considered 



















Chapter 5: Results 
Preliminary Data: Location Differences 
 Statistical analysis was completed using repeated measures ANOVAs and 
repeated measures t-tests.  A 2 x 15 (location x frequency) ANOVA with repeated 
measures on both factors indicated no significant differences between locations, F(1, 
9) = 2.82, p = 0.13.  Main effect of frequency and interactions could not be calculated 
due to the low degrees of freedom.  The mean difference between locations was < 1% 
ER across frequencies (differences ranged from –4.1% to 2.3% ER) and the mean 
difference in standard deviations between locations was 0.76 across the frequency 
range (ranged from –4.1 to 2.3).  The comparisons between the mean ER data are 
displayed in Figures 8 and 9.  
A 2 X 15 (test x frequency) ANOVA with repeated measures on both factors 
indicated no significant differences between test-retest measurements, F(1, 9) = 
1.987, p = 0.32.  Main effect of frequency and interactions could not be calculated 
due to the low degrees of freedom.  The average difference between the first  and 
second run within individuals using a different probe fit at the same location was 
0.15% (± 1.5 SD) at the National Institutes of Health, and 0.42% (± -2.06 SD) at 
University of Maryland, College Park.  The comparisons between the test-retest of 
different probe fits recorded at the National Institutes of Health are displayed in 
Figure 10.  Comparable findings were found at the University of Maryland, College 
Park and are not shown.  ER measurements in this sample of young normal adults 
were comparable to existing normative data (Feeney et al., 2002; Keefe et al., 2003; 
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Figure 9.  Mean ER plotted as a function of frequency (N = 10 ears) with error bars representing ±1 SD from the mean, compared 






























Figure 10.  Test-retest measurements obtained at National Institutes of Health.  Mean 
ER plotted as a function of frequency (N = 10 ears) with error bars representing ±1 
SD from the mean, compared between first (closed symbols) and second (open 








Audiometric and immittance measures were consistent between locations.  
Air- and bone-conduction threshold differences between locations were all within ±5 
dB for each test frequency, which is consistent with expected test-retest reliability.  A 
2 x 9 (location x frequency) ANOVA with repeated measures on both factors 
indicated no significant differences in air conduction thresholds between locations, 
F(1, 9) = 0.03, p = 0.81.  Main effect of frequency and interactions could not be 
calculated due to the low degrees of freedom.  A 2 x 4 (location x frequency) 
ANOVA with repeated measures on both factors indicated no significant differences 
in bone-conduction thresholds between locations, F(1, 9) = 3.45, p = 0.10.  Main 
effect of frequency and interactions could not be calculated due to the low degrees of 
freedom.  A 2 x 3 (location x frequency) ANOVA with repeated measures on both 
factors indicated no significant differences in DPOAE level between locations, F(1, 
9) = 2.19, p = 0.17.  Main effect of frequency and interactions could not be calculated 
due to the low degrees of freedom.  All individuals passed the DPOAE screening 
criteria at both locations.  
Identical values were obtained for 226-Hz static admittance between locations 
and, therefore, static admittance was not significantly different between locations      
(t = 0.0, p = 1.0).  There were no statistically significant differences in TPP (t = -0.56, 
p = 0.59).  TPP was within ±10 daPa for all individuals at both locations, with an 
average difference of 5 daPa between locations and a difference range of 0 – 10 daPa 
(SD = 4.7).  Multifrequency tympanometry maintained identical qualitative shapes 
(notched versus single peaked) between locations.  Static admittance values for 678- 




1.96, p = 0.08; t = 1.80, p = 0.10, respectively).  The mean difference for static 
admittance values of a 678-Hz admittance tympanogram was 0.14 mmhos (SD = 
0.18) and a 1000-Hz admittance tympanogram was 0.18 ml (SD = 0 .16).  There were 
no significant differences between locations (t = -1.08, p = 0.31).  The average 
difference in resonant frequency values between locations was 40 Hz, with a range of 
0-100 (SD = 45.9).  The mean resonant frequency was 1070 Hz (SD = 170) at the 
National Institutes of Health and 1090 (SD = 151) at the University of Maryland, 
College Park.   Based on these results, which revealed no statistical differences 
between locations, testing was conducted at two locations. 
Preliminary Data: Test Order 
All participants had normal 226-Hz tympanograms with a single peak, normal 
static admittance values (range 0.4-1.1 ml), and normal TPP (±10 daPa).  Mean ER 
data and mean ER ±1 SD for each test condition are shown in Figures 11 and 12, 
respectively.  A 2 x 15 (test x frequency) ANOVA with repeated measures on both 
factors indicated no significant differences between pre- and post-tympanometry ER 
measurements, F(1, 9) = 0.04, p = 0.85. Main effect of frequency and interactions 
could not be calculated due to the low degrees of freedom.  Based on this preliminary 




The prevalence of hearing impairment did not significantly differ between 





























Figure 11. Mean ER plotted as a function of frequency (N = 10 ears) compared 
between measurements obtained before (closed symbols) and after a 226-Hz 































Pre-tympanogram +/- 1 SD
Frequency (Hz)
250 400 630 1000 1600 2500 4000 6000






Figure 12.  Mean ER plotted as a function of frequency (N = 10 ears) with error bars representing ±1 SD from the mean, compared 




comparisons with previous literature, three different criteria were used to define 
hearing loss, and prevalence of hearing loss was determined for each group using 
each of the three criteria.  Hearing loss was defined as the presence of hearing 
thresholds at two or more frequencies in the tested ear that were (1) greater than 15 
dB HL, (2) greater than 20 dB HL, or (3) greater than 25 dB HL.  Table 3 lists the 
number of ears and participants in each group that presented with hearing loss for 
each of the three criteria.  A conductive component was defined as the presence of an 
air-bone gap of greater than 10 dB HL at two or more frequencies in the tested ear.  A 
chi-square test of independence comparing the presence or absence of hearing loss 
was not significantly different between groups for any of the three hearing loss 
criteria: greater than 15 dB HL, χ2 (1, N = 38) = 0.10 (p > 0.05); greater than 20 dB 
HL, χ2 (1, N = 38) = 0.0 (p > 0.05); or greater than 25 dB HL, χ2 (1, N = 38) = 0.47 (p 
> 0.05).  No individuals in either group presented with a conductive or mixed type of 
hearing loss.    
Based on this study’s criterion for hearing loss at greater than 20 dB HL, eight 
individuals in the RA group presented with sensorineural hearing loss: seven were 
bilateral and one was unilateral.  Two of the individuals were male, ages 59 and 60 
years, and six were female, ages 42, 47, 57, 59, 61 and 63 years, with a mean age of 
56 years (SD = 7.4 years).  Hearing loss was generally found in the high-frequencies 
and the degree varied across individuals: six had a mild hearing loss, one had a 
moderate hearing loss, and one had a severe hearing loss.  In the NC group, eight 
individuals presented with sensorineural hearing loss. Two were male, ages 60 and 63 








Comparisons of Hearing Loss at Different Threshold Classifications 
Group > 15 dB HL 
Ears; Participants 
> 20 dB HL 
Ears; Participants 
> 25 dB HL 
Ears; Participants 
    
RA 23; 13 15; 8 9; 5 
NC 21; 12 15; 8 13; 7 
 
Note. Hearing loss was defined as the presence thresholds poorer than the threshold 















60.25 years (SD = 2.6 years).  The mean age of participants with hearing loss was not 
significantly different between groups (t = 1.53; p = .15).  In the NC group, all of the 
affected participants had bilateral hearing losses.  However, one individual had one 
ear excluded due to scarring on the tympanic membrane and a significant otologic 
history for ear infections in that ear.  Therefore, in total, there were 15 ears with 
hearing loss in the NC group included in data analysis.  Most individuals presented 
with a mild to moderate high-frequency hearing loss with elevated thresholds at 6000 
and 8000 Hz.  The number and percentage of individuals with hearing loss (8/21; 
38%) and the number and percentage of ears with hearing loss (15/38; 39%) were the 
same in both the RA and NC groups.  By comparing different hearing loss threshold 
level classifications between groups, the lower threshold (greater than 15 dB HL) 
included hearing losses which were typically a slight high-frequency sensorineural 
hearing loss.  Similarly, the more stringent criteria (greater than 25 dB HL) 
eliminated individuals with mild high-frequency hearing loss.  Despite the varying 
criteria, the prevalence of hearing loss was comparable between groups. 
 A 2 x 10 (group x frequency) ANOVA with repeated measures on the second 
factor was used to compare the mean air-conduction thresholds between groups.  
Figure 13 illustrates mean air-conduction thresholds for both groups.  Air-conduction 
thresholds were not significantly different between groups, F(1, 74) = 1.87, p = 0.18.  
As might be expected, a significant effect of frequency was found for air-conduction 
thresholds, F(2, 154) = 19.41, p = 0.0001.  There was not a significant interaction 
between group and frequency for air-conduction thresholds, F(2, 154) = 1.89, p = 




for high-frequencies in air-conduction thresholds compared to lower- and mid-
frequencies.  Air-conduction frequencies at 6000 and 8000 Hz were significantly 
worse than all other frequencies, and 8000 Hz was worse than 6000 Hz.   
A 2 x 4 (group x frequency) ANOVA with repeated measures on the second 
factor was used to compare the mean bone-conduction thresholds between groups.  
Bone-conduction thresholds were not significantly different between groups, F(1, 74) 
= 1.02, p = 0.32.  There was a significant effect of frequency, F(2, 135) = 10.01, p = 
0.0001, and a significant interaction between group and frequency for bone-
conduction thresholds, F(2, 135) = 4.11, p = 0.02.  Pairwise comparisons of 
frequency revealed significant differences (p < 0.05) for high-frequencies in bone-
conduction thresholds.  Bone-conduction thresholds at 4000 Hz were significantly 
worse than at all other frequencies.  This was expected due to the presence of high 
frequency hearing loss.  The mean and standard deviation values for bone-conduction 
thresholds are shown in Table 4. 
A 2 x 4 (group x frequency) ANOVA with repeated measures on the second 
factor was used to compare air-bone gaps between groups.  There was not a 
significant difference between groups, F(1, 74) = 3.71, p = 0.06.  A significant effect 
of frequency was found, F(3, 200) = 2.89, p = 0.04.  However, pairwise frequency 
comparisons were not significant at p < 0.05 level.  There was not a significant 
interaction between group and frequency, F(3, 200) = 1.57, p = 0.20.  Table 5 
displays comparisons between groups across frequencies. 
In the present study, 38% of the ears from both the RA group and NC group 







































Figure 13. Mean air-conduction thresholds compared between RA (filled circles) and 
NC (shaded triangles) groups (N = 38 ears per group).  Error bars represent  ±1 SD 















Mean Bone-Conduction Thresholds Compared Between Groups 
_____________________________________________________________________ 
 
  Frequency (Hz)                 RA Group  (dB HL)           NC Group (dB HL) 
     M (± SD)                                       M (± SD) 
_______________                       _______________                        _______________ 
 
 500    10.5 ± 4.7       13.6 ± 8.4 
 1000    12.2 ± 5.9       10.5 ± 7.1 
 2000    14.9 ± 7.8       10.9 ± 6.4 
 4000    18.4 ± 14.1       15.3 ± 10.3 
 



















Mean Air-Bone Gap Differences Compared Between Groups  
 
 
  Frequency (Hz)                 RA Group  (dB HL)           NC Group (dB HL) 
     M (± SD)                                       M (± SD) 
_______________                       _______________                        ______________ 
 
 500    2.11 ± 3.42     1.32 ± 2.77 
 1000    2.37 ± 3.23     1.71 ± 3.14 
 2000    1.05 ± 2.07     1.18 ± 2.15 
 4000    1.84 ± 2.71     0.26 ± 1.13  
 















more frequencies. However, this definition does not account for an expected decrease 
in hearing that is associated with age and, therefore, comparisons were made with 
existing normative data for hearing thresholds based on age and gender.  Figure 14 
shows the air-conduction thresholds for each ear tested in both groups as a function of 
age.  The dashed and solid dray lines represent the 50th and 95th percentiles, 
respectively, based on normative data collected by Morrell, Gordon-Salant, Pearson, 
Brant, and Fozard (1996) at frequencies between 500-4000 Hz, and standards 
reported by the International Organization for Standardization for 8000 Hz (ISO, 
1984).   
The number of thresholds across frequencies that were poorer than the 95th 
percentile (ISO 1984; Morrell et al., 1996) are shown in Table 6.  The three-
frequency PTA was included in the table for comparison, but was not included in 
totals or statistical analysis due to its duplicative nature with the 500, 1000 and 2000 
Hz discrete frequency comparisons.  A chi-square test of independence using nominal 
categorical variables of the presence or absence of hearing thresholds that were 
poorer than the 95th percentile revealed a significant difference between groups at the 
p < 0.001 level, χ2 (1, N = 190) = 15.75.  Analysis included results for both genders 
for 500, 1000, 2000, 4000, and 8000 Hz. A greater number of thresholds from those 
participants with RA were poorer than the 95th percentile across the test frequencies.   
Standard Immittance 
 
Middle ear measurements were classified as normal or abnormal, as 
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Figure 14. Air conduction thresholds for two groups as a function of age at six 
different frequencies, with comparison to normative data from Morrell et al. (1996) 
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Number of Ears with Air-Conduction Thresholds Poorer than the 95th Percentile 






































1000 10 1 0 0 
2000 12 3 0 0 
4000 7 2 2 0 
8000 0 0 0 0 













Note. A significant difference between groups was found (p < 0.001) for the total 







1993; Margolis & Heller, 1987).  Mean peak compensated static admittance and ear 
canal volume obtained from the 226-Hz tympanograms are listed for both groups in 
Table 7.  Neither measure was significantly different between groups: static 
admittance (t = 0.80, p = 0.42); ear canal volume (t = 0.08, p = 0.94).  Two ears from 
the same individual in the RA group had abnormally high static admittance values 
(great than 1.7 mmhos) and no ears had low static admittance (less than 0.3) 
compared to normative data (Margolis & Goycoolea, 1993).  No individuals from the 
NC group had a static admittance value outside this normative range (0.3 – 1.7 
mmhos).  The TPP was significantly different between groups (t = -3.31, p = 0.001). 
All ears of NC participants had a TPP within ±10 daPa; however, 10/38 ears in 
the group with RA had TPP not within ±10 daPa.  All TPP measurements included in 
data analysis were considered clinically normal and were within –150 to +50 daPa.  
Most ears had TPP within –50 to +50 daPa.  Only one individual had an ear with TPP 
lower than -100 daPa.  Other measurements (e.g., audiometric pure-tone thresholds, 
resonant frequency etc.) obtained from the individual with TPP = -140 daPa were 
within ±1 SD of the group means. While there was a statistically significant difference 
in TPP between groups, the values were still within clinical normal limits.  The TPP 
could potentially influence the results were ER and DPOAE measures.  The 
equipment used for ER and DPOAE does not compensate for TPP; and, therefore, the 
10 ears from the RA group and the corresponding normal control ears were excluded 
from analyses of the ER and DPOAE data.   
Tympanometric width was also recorded; however, due to differences in how 








226-Hz Tympanometric Static Admittance (Y), Ear Canal Volume (ECV), and 
Tympanometric Peak Pressure (TPP) Measurements Compared Between Groups  
 
Measure 
               RA 
Mean      SD        Range   
               NC 















ECV (cm3) 1.41 0.33 0.7-2.1 1.40 0.26 1.0-1.9 
TPP (daPa)* -15.0 29.43 (-140)-(+30) 1.32 5.16 (-10)-(+10) 
 












comparisons between groups cannot be made1.  The mean tympanometric width in 
the RA group was 109.34 daPa (SD = ±68.41).  Tympanometric width was abnormal 
in 20/38 ears in the RA group.  Tympanometric width greater than 115 daPa was 
recorded in 13/38 ears, of which 5/38 were greater than 200 daPa. Tympanometric 
width less than 50 daPa was recorded in 7/38 ears.  Estimates of the NC group 
tympanometric width revealed no ears had a width greater than 115 daPa, and 5/38 
ears had a width less than 50 daPa.   
The means and standard deviations for acoustic reflex thresholds (ARTs) 
obtained from each group are listed in Table 8.  Thirty-three ears from each group 
were included in the analysis.  A 2 x 6 (group x frequency) ANOVA with repeated 
measures on the second factor was used to compare the mean ARTs between groups.  
ARTs were not significantly different between groups, F(1, 64) = 0.61, p = 0.44.  A 
significant effect of frequency was found for ARTs, F(3, 176) = 38.11,  p = 0.0001, 
and no significant interaction between group and frequency, F(3, 176) = 0.53, p = 
0.64.  Pairwise comparisons of frequency revealed significant differences  (p < 0.05) 
between almost all test conditions.  Acoustic reflex adaptation was measured when 
possible (stimulus level  ≤110 dB HL) at 500 and 1000 Hz in the contralateral test 
condition.  This included 30/38 ears at 500 Hz and 34/38 ears at 1000 Hz in the RA  
group, and 31/38 at 500 Hz and 31/38 ears at 1000 Hz in the NC group.  All 
individuals tested exhibited negative reflex adaptation.   
                                                 
1 The GSI-33 Middle Ear analyzer at University of Maryland, College Park (CP) could not 
automatically calculate tympanometric width.  Manual estimates were obtained at CP; however, 
comparisons between manual calculations and automatic calculations using the GSI-33 at the National 
Institutes of Health revealed differences of 5 – 10 daPa dependent on the method of calculation.  











Acoustic Reflex Thresholds Compared Between Groups 
 
Frequency (Hz) 
               RA 
  Ipsi                    Contra   
               NC 
Ipsi                        Contra 
 









1000  M (SD) 83.94(5.70)  90.91(5.79) 86.21(7.81)  91.97(7.28) 
2000  M (SD) 86.82(6.10)  91.36(6.16) 87.88(7.91)  92.73(8.12) 
 




























Additional susceptance (B) and conductance (G) tympanograms were 
obtained using probe tones of 678- and 1000-Hz.  In the RA group, 19/38 ears had a 
notch in the 678-Hz B-tympanogram, compared to 12/38 ears in the NC group. The 
proportion of notched versus single-peaked tympanograms at 678-Hz was not 
significantly different between groups using a chi-square test, χ2 (1, N = 38) = 2.67, p 
> 0.05.  Tympanometric shape patterns were determined using the Vanhuyse model 
(Vanhuyse et al., 1975).  The shape classifications of the 678-Hz probe tone are 
compared between groups in Figure 15.  In the RA group, 19 ears had a 1B1G 
pattern, 16 ears had a 3B1G pattern, two ears had a 3B3G pattern, and one ear did not 
follow any patterns with notching occurring at more than one pressure.  In the NC 
group, 26 ears had a 1B1G pattern, and 12 had a 3B1G pattern.  Ten ears in the RA 
group and five ears in the normal control group had a midpoint notch value that was 
equal to or less than the value of the tail of the tympanogram, indicating a middle ear 
system that is mass dominated. 
Results for a 1000-Hz tympanogram revealed notched B-tympanograms for 
35/38 ears in the RA group and 36/38 ears in the normal control group.  The 
proportion of notched versus single-peaked tympanograms at 1000-Hz was not 
significantly different between groups using a chi-square test, χ2 (1, N = 38) = 2.67, p 
> 0.05.  Tympanometric shapes for the 1000-Hz probe tone are plotted for each group 
in Figure 16.  Results in the RA group revealed three ears had a 1B1G pattern, 21 ears 
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Figure 15.  Tympanometric shape obtained for 678-Hz tympanograms by 38 ears in 
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Figure 16.  Tympanometric shape obtained for 1000-Hz tympanograms by 38 ears in 












patterns with notching occurring at more than one pressure.  This was the same 
individual that had an “other” classification when using a 678-Hz probe tone.  In the 
NC group, two ears were consistent with a 1B1G pattern, 35 were consistent with a 
3B1G pattern, and one ear was consistent with a 3B3G pattern. Thirty four of the 38 
ears in both the RA group and the NC group had a central notch value that was equal 
to or less than the value of the tail of the B-tympanogram indicating the middle ear 
system becoming mass dominated.   
Admittance values measured at the positive tails (+200) and midpoints of 678- 
and 1000-Hz tympanograms were also compared between groups.  Data for the two 
groups are listed in Table 9.  Comparisons of mean Ymidpt  did not significantly differ 
between groups at 678-Hz (t = -.96; p = 0.34) or at 1000-Hz (t = 0.578; p = 0.57).  
Additionally, there were no statistically significant differences between groups for 
Y+200 at 678-Hz (t = 0.54; p = 0.59) or at 1000-Hz (t = 1.54; p = 0.13). 
The middle ear resonant frequency was calculated by the GSI-33 middle ear 
analyzer using a multi-frequency sweep from 200-2000 Hz in 50 Hz steps.  The RA 
group had a significantly lower resonant frequency compared to the NC group (t = 
3.36, p < 0.001).  For the RA group, the mean resonant frequency was 790 Hz, the 
median was 825 Hz, and the range was 250-1150 Hz.  For the NC group, the mean 
resonant frequency was 967 Hz, the median was 950 Hz, and the range was 550-1700 
Hz.  Figure 17 displays box plots representing the resonant frequency from the 5th to 
95th percentiles compared between groups.  Valvik et al. (1994) found a 90% range of 
650-1500 Hz using comparable equipment and methods for middle ear resonant 






















678-Hz   
Y+200 4.01 (0.86) 4.10 (0.68) 
Ymidpt 3.09 (1.86) 2.74 (1.27) 
   
1000-Hz   
Y+200 6.20 (1.30) 6.66 (1.34) 
Ymidpt 3.96 (1.93) 4.22 (2.07) 
 




































Figure 17.  Box plots of middle ear resonant frequencies for the 38 ears in each 
group.  Data are shown in percentiles: the 10th and 90th percentiles are represented by 
the edges of the boxes and the 25th and 75th percentiles are represented by the error 
bars.  The 5th and 95th percentiles are represented by the dots, and the mean is 
indicated by the line in the box plot. The RA group had significantly lower resonant 









zero ears above 1500 Hz.  In the NC group, two ears had a resonant frequency below 
650 Hz and one ear above 1500 Hz.  A low resonant frequency is consistent with an 
increased mass dominance of the middle ear system. 
An additional analysis was conducted to ensure the validity of the significant 
middle ear resonant frequency findings.  Valvik et al. (1994) reported that when the 
susceptance slope is flat close to the point at which susceptance is equal to zero, there 
may be variable resonant frequency results and poor test-retest within an individual.  
The outliers for both high and low resonant frequency values in both groups were 
reviewed, and the individual in the NC group with abnormally high resonant 
frequency had a flat susceptance slope.  Statistics were repeated excluding this NC 
participant with a resonant frequency of 1700 Hz and excluding the matched 
participant in the RA group.  A statistically significant difference in the resonant 
frequency was still found between groups (t = 3.17; p = .002) when these data were 
excluded.   
Tympanometric and pure-tone audiometric results were compared within 
individuals in the RA group to examine for possible relationships across 
measurements.  These comparisons for 21 participants (38 ears) in the RA group are 
displayed in Table 10.  Static admittance values for 226 Hz tympanograms greater 
than 1.7 mmhos are listed as “high.” The column representing 678- and 1000-Hz 
tympanograms lists the shape according to Vanhuyse et al. (1975).  Only ears for 
which notching occurred are listed.  No ears had a notched tympanogram at 226-Hz.  
The resonant frequency was considered low for frequencies less than 650 Hz, and 






Comparisons of Tympanometry and Pure-tone Audiometry Measures for Ears of Individuals  
in the RA Group 
 Age/Sex 
 
  Ear 
226-Hz 
(mmhos) 678-Hz 1000-Hz Res. Freq. (Hz)
HL >     
20 dB HL 
HL >  
Age 
24-F R     1150  yes 
24-F L      1100   yes 
29-F R  3B1G 3B3G  700  yes 
29-F L    3B1G   950   yes 
35-F R  3B1G 3B1G  700  yes 
35-F L   3B1G 3B1G  1000   yes 
42-F R  3B1G 3B1G  750 yes yes 
42-F L   3B1G 3B3G  850   yes 
44-F R  3B1G 3B3G  700   
44-F L   3B1G 3B3G  750     
45-M L  3B1G 3B3G 600 (low)   
47-F R    3B1G  850   yes 
47-F R   3B3G  800 yes yes 
47-F L   3B1G 3B3G     600 (low) yes yes 
47-F R   3B1G  900   
47-F L   3B1G 3B1G  900     
51-F R  3B1G 3B1G   350 (low)   
51-F L    3B1G   550 (low)     
57-F R  Other Other   250 (low) yes  
57-F L   3B1G 3B3G   550 (low)  yes   
59-F R  3B3G 3B3G  850 yes  
59-F L    3B1G  900  yes   
59-F R 2.4 (high) 3B1G 3B3G 550 (low)   
59-F L 4.8 (high) 3B3G 3B3G 400 (low)     
59-F R   3B1G 500 (low)   
59-F L    3B1G  1050      
59-F R   3B1G  900   
59-M R    3B1G  800 yes yes 
59-M L   3B1G  800 yes yes 
60-M R    3B1G  950 yes yes 
60-M L  3B1G 3B3G  750 yes yes 
61-F R  3B1G 3B3G  950 yes yes 
61-F L  3B1G 3B1G  950 yes yes 
62-F L      1050     
63-F R   3B1G  800 yes  
63-F L    3B1G  900 yes   
64-M R    3B1G  1050     
64-M L    3B1G  900     
 





RA group had a “high” resonant frequency.  The multiple middle ear measurements 
generally are consistent with each other.  Individuals with notching at 678-Hz also 
had notching at 1000-Hz probe tones. Individuals with a low resonant frequency 
generally had more complex tympanometric shapes.   
 Table 10 also compares ears with hearing loss at two frequencies greater than 
20 dB HL with at least one frequency poorer than the 95th percentile based on age and 
gender (Morrell et al., 1996).  There were no visible trends with middle ear function 
(e.g., notching, low resonant frequency) and the presence of hearing loss, but older 
individuals tended to have hearing loss greater than 20 dB HL.  Many young 
individuals in the RA group had air-conduction thresholds poorer than normative data 
for the 95th percentile. 
Energy Reflectance (ER) Measures 
ER values, expressed as percentage, were compared between groups, using 
the subset of participants with TPP ±10 daPa (28 ears in each group).  A 2 x 15  
(group x frequency) ANOVA with repeated measures on the second factor indicated 
that ER values were not significantly different between groups, F(1, 54) = 0.038, p = 
0.85.  As might be expected, an effect of frequency was found, F(3, 171) = 155.27, p 
= .0001.  There was not a significant interaction between group and frequency, F(3, 
171) = .63, p = 0.61.  Pairwise comparisons revealed significant differences between 
most frequencies, with the exceptions being the mid-frequencies (1000-3175 Hz) and 
the frequencies at the high and low extremes where ER values were not significantly 
different.  Figure 18 displays mean ER for the two groups.  Figure 19 displays the 





























Figure 18.  Mean percent of ER plotted as a function of frequency on a logarithmic 
scale and compared between RA (filled circles) and NC (open circles) groups (N = 28 









































































Figure 19. Mean percent of ER plotted as a function of frequency on a logarithmic scale for the RA group (left panel) and the NC 




The ER curves were further analyzed by comparing three different values 
obtained from the curve: (a) the frequency at which the least amount of ER occurred; 
(b) the value of the least amount of ER in each participant; and (c) the area under the 
ER curve.  Values for both groups are listed in Table 11.  No significant differences 
(p > 0.05) were found between groups for frequency of least ER (t = -.12, p = 0.90), 
percent of least amount of reflected energy (t = 0.16, p = 0.87), and area under the ER 
curve (t = -.82, p = 0.42). 
DPOAE Measures 
DPOAE levels were measured in the subset of 21 participants (28 ears) in 
each group with TPP within ±10 daPa.  Based on screening criteria (DPOAE level ≥ 
10 dB SPL and DPOAE level ≥ 6 dB above the noise floor at all tested frequencies), 
9/28 ears from 5 individuals in the RA group failed the screening criteria and 4/28 
ears from 3 individuals in the NC group failed the screening criteria.  Most of the 
individuals (7/8) who failed the screening were the same individuals that presented 
with hearing loss.  One individual from the RA group did not have hearing loss, but 
failed the DPOAE screening bilaterally.  However, this individual had the highest 
static admittance values between the two groups (4.8 and 2.4 mmhos), as well as 
middle ear resonant frequencies more than 1 SD below the mean for the RA group  
(550 and 400 Hz).   
A 2 x 3 (group x frequency) ANOVA with repeated measures on the second 
factor indicated no significant difference in DPOAE level between groups, F(1, 54) = 
1.03, p = 0.32.  There was not a main effect of frequency, F(2, 108) = 2.52, p = 0.09.  












Mean         SD            Range 
NC 
Mean         SD           Range 
 















Value of least ER 
(%) 
 
12.5 11.47 0.05-33.31 12.1 9.08 0.67-33.55 
Area under curve 271,585 53,744 130,549- 
350,335 
259,944 52,798 117,275- 
355,537 
 















1.46, p = 0.24.  Mean and standard deviations of DPOAE amplitude levels are 
presented in Table 12. 
RA Disease Activity and Audiological Measures 
 
 The participants in the RA group had varying levels of disease involvement, 
as previously detailed in Table 1.  Correlation analysis was performed to determine 
whether there was a relationship between various markers for disease involvement 
and either air-conduction thresholds or middle ear resonant frequency.  One ear from 
each of the 21 participants in the RA group was selected at random for inclusion in 
the analysis.  Measures of RA disease involvement included the level of inflammation 
as determined by ESR levels, number of swollen joints as determined by physicians’ 
examination, and length of disease duration.  The audiological measures were 
selected due to the significant differences noted between groups when comparing 
thresholds to age-related normative data for air-conduction thresholds, and the 
significantly lower resonant frequency in the RA group.  Table 13 lists the Pearson’s 
r and the level of significance for a partial correlation accounting for age and 
examining a relationship between RA disease factors and air-conduction thresholds 
and middle ear resonant frequency.   
The analysis revealed a significant positive correlation between increasing 
disease duration and poorer air-conduction thresholds at 4000-8000 Hz.  Figure 20 
displays air-conduction thresholds at 4000 Hz and Figure 21 displays air-conduction 
thresholds at 8000 Hz as a function of disease duration.  Individuals with RA who had 
longer disease duration had more hearing loss in the high-frequencies, even when 














     
     RA 
 
     
    NC 
 
 M ± SD 
(dB SPL) 
 
M ± SD 
(dB SPL) 
2000 2.91 ± 12.08 4.07 ± 7.64 
3000 0.71 ± 14.39 3.83 ± 6.38 
4000 0.32 ± 13.93 2.77 ± 8.29 
 



















Partial Correlations Accounting for Age and Comparing RA Disease Involvement 



















500 Hz -.13 (.58) .11 (.64) .16 (.51) 
750 Hz -.39 (.09) -.05 (.83) .33 (.16) 
1000 Hz -.12 (.63) 11 (.64) .19 (.41) 
1500 Hz -.25 (.29) -.02 (.92) .15 (.54) 
2000 Hz -.19 (.41) .11 (.64) .23 (.32)  
3000 Hz .14 (.56) .13 (.60) .29 (.22) 
4000 Hz .17 (.47) -.04 (.87) .50 (.03)* 
6000 Hz .22 (.34) -.05 (.84) .53 (.02)* 
8000 Hz .19 (.42) -.06 (.81) .53 (.02)* 










Note.  (*) indicates significant correlations at the p < 0.05 level.  One ear was chosen 










































r = 0.50 
 
Figure 20. Scatter plot with regression line plotting the air-conduction threshold at 













































r = 0.53 
 
Figure 21. Scatter plot with regression line plotting the air-conduction threshold at 













to be skewed by two older participants with long disease duration.  A 59 year-old 
male with disease duration of 30 years, and a 61 year-old female with disease 
duration of 38 years both had hearing loss at 4000 Hz and 8000 Hz.  When 
correlations were repeated without these two individuals, no significant correlations 
were observed.  There were no correlations with air-conduction thresholds or resonant 
frequency and ESR levels or the number of swollen points in individuals with RA.   
Although the RA group in the present study was on a variety of medication 
regimens, no observable trends were found regarding abnormalities in the auditory 
system and the medications listed in Table 1.  The data were examined by comparing 
individuals with hearing loss, middle ear abnormalities and category of medications; 
however, review of the data did not display any patterns (e.g. abnormal middle ear 
function and use of a certain type of medication).  The individuals with hearing loss 














Chapter 6:  Discussion 
Audiometric Measures 
 
The purpose of this study was to determine whether individuals with RA had a 
greater prevalence of middle ear abnormalities and/or hearing loss compared to a 
group of NC participants.  The groups were matched 1:1 for age and gender and 
carefully selected, excluding individuals from both groups based on criteria regarding 
middle ear history and medical history.  The RA group was no more likely than the 
NC group to have hearing loss.  This finding is inconsistent with the majority of 
previous studies in which a higher prevalence of hearing loss in individuals with RA 
than NC participants was reported (Goodwill et al., 1971 & 1972; Kastanioudakis et 
al., 1995; Magaro et al., 1990; Özcan et al., 2002, Raut et al., 2001; Salvinelli et al., 
2004 & 2006; Takatsu et al., 2005).  Participants in this study presented only with 
sensorineural hearing loss, which is consistent with several previous studies (Biasi et 
al., 1996; Goodwill et al., 1972; Kastanioudakis et al., 1995; Magaro et al., 1990).  No 
instances of a conductive or mixed hearing loss were found, unlike other previous 
reports by other researchers (Raut et al., 2001; Salvinelli et al., 2004).  However, 
sensorineural hearing loss has been the most common type of hearing loss reported in 
patients with RA across the literature (Kastanioudakis et al., 1995; Magaro et al., 
1990). 
The variance of the prevalence of hearing loss across studies may be attributed 
to a variety of factors, including differences in criteria used to define presence and 
type of hearing loss. Definitions of hearing loss have included the following: 




al., 1995; Raut et al., 2001; Takatsu et al., 2005); thresholds greater than 25 dB HL at 
one or more test frequencies (Halligan et al., 2006); thresholds ≥ 20 dB HL above the 
age-corrected level at two or more test frequencies (Öztürk et al., 2004); and greater 
than 20 dB below the accepted normal for the age group at two or more test 
frequencies (Elwany et al., 1986; Özcan et al., 2002).  For those using age-
corrections, the processes were not clearly explained, and this limited information 
about study design may also lead to inconsistencies among age-related results.  
Additionally, some previous studies did not clearly define any criteria for hearing loss 
(Djupesland et al., 1973; Goodwill et al., 1972; Reiter et al., 1980; Salvinelli et al., 
2004).  A clearly defined and controlled study by Halligan et al. (2006) reported that 
hearing loss was no more likely in individuals with RA compared to NC indivduals, 
consistent with the current study’s results.    
Thresholds at 20 and 25 dB HL are considered a slight hearing loss (Clarke, 
1981). The inclusion of a slight hearing loss without adjusting for age may inflate the 
prevalence of hearing loss, particularly in a population of individuals who tend to be 
older adults.  For example, in the current study, seven ears from four individuals in 
the RA group would not have met the criteria for abnormal hearing if it was extended 
to greater than 25 dB HL at two or more frequencies.  However, for comparison 
purposes the criteria of this study were varied to allow for comparison to a variety of 
studies.  
The disparities across studies were most notable when comparing definitions 
of a conductive component.  Raut et al. (2001) and Takatsu et al. (2005) defined a 




or more frequencies, and Özcan et al. (2002) used an air-bone gap greater than 5 dB 
as the significant criterion for a conductive component.  Not surprisingly, Özcan et al. 
(2002) reported a higher prevalence of mixed or conductive hearing loss, 9/37 
individuals with RA, compared to 6/35 and 0/36 from Raut et al. (2001) and Takatsu 
et al. (2005), respectively.  Other studies did not clearly define criteria.  Elwany et al. 
(1986) reported that one individual with an air-bone gap had a difference of 40 dB. 
These findings were in stark contrast to the prevalence of air-bone gaps reported by 
Salvinelli et al. (2004).  The authors stated that most individuals had an air-bone gap, 
but did not state their criterion for a difference.  Less stringent criterion may explain 
why 28/38 individuals with RA in their study had either a mixed or conductive type 
of hearing loss.  The differences in criteria for a significant air-bone gap across 
studies make it difficult to make comparisons regarding the prevalence of different 
types of hearing loss in persons with RA.  It appears that the prevalence of conductive 
and mixed hearing loss in some studies may be inflated due to questionable 
classification criteria, and that sensorineural hearing loss is the most prevalent 
finding.   
The prevalence of hearing loss was not significantly different between the two 
groups in the current study, and there also were no significant differences between 
air- and bone-conduction thresholds.  Other previous studies reported significant 
differences between air- and bone-conduction thresholds in individuals with RA 
compared to age- and gender-matched NC groups.  Differences were most often 
reported in the mid-frequency range (500-2000 Hz) (Raut et al., 2001; Salvinelli et 




bone-conduction thresholds.  This frequency effect was expected because most 
participants had a high-frequency sensorineural hearing loss. 
Despite the lack of difference between groups when comparing thresholds, 
significantly more ears from the RA group than the NC group had thresholds poorer 
than the 95th percentile for individuals in their age range.  Most individuals in the NC 
group who presented with clinical hearing loss were within the expected pattern of 
age-related hearing loss.  In the RA group, younger individuals tended to have air-
conduction thresholds poorer than those expected for their age.  Both males and 
females in the RA group presented with thresholds poorer than normative data, 
occurring most frequently in the mid-frequency range (1000-2000 Hz).   While these 
thresholds were generally within clinically normal limits, these significant differences 
provide evidence of subtle differences in hearing sensitivity in those with RA 
compared to those without the disease.   This finding emphasizes the need for 
consideration of age, and comparisons to age-appropriate normative data.  Because 
the typical age range of individuals with RA spans the fourth to eighth decades of life, 
it is important to consider effects of aging when classifying hearing as normal or 
abnormal.   
Studies that did not account for effects of aging may have overestimated the 
impact of RA on hearing.  Several studies did not mention comparisons to normative 
data based on age or make adjustments accounting for effects of age (Kastanioudakis 
et al., 1995; Raut et al., 2001; Salvinelli et al., 2004).  Given that the majority of 
hearing loss reported was a high-frequency sensorineural hearing loss, aging is an 




hearing loss was typically in the high frequencies in both the RA and NC groups, no 
individuals in either group had a threshold poorer than the 95th percentile based on 
age and gender at 8000 Hz.  However, other studies have factored in age-correction 
processes, and they still found a greater prevalence of hearing loss in the RA group 
compared to age- and gender-comparable NC groups (Elwany et al., 1986; Özcan et 
al., 2002; Öztürk et al., 2004).  The results of the present study also indicated 
differences in the thresholds from individuals in the RA group compared to expected 
effects of aging, more notably in the younger participants.  
Standard Immittance 
 
Standard immittance measurements, including 226-Hz tympanometry static 
admittance and acoustic reflex thresholds, were not significantly different between 
the RA group and the NC group.  Two ears from the same individual in the RA group 
had abnormally high static admittance (greater than 1.7 mmhos), but no ears in either 
group had reduced admittance (less than 0.3 mmhos), similar to the findings of Raut 
et al. (2001). The studies that have reported abnormal 226 tympanograms in patients 
with RA generally found type As tympanograms or reduced admittance values, which 
is consistent with an increase in stiffness (Elwany et al., 1986; Öztürk et al., 2004; 
Takatsu et al., 2005).  However, some of these data may be misleading.  For example, 
Salvinelli et al. (2004) reported individuals with active RA had reduced admittance, 
but their tympanograms were classified as Type A and no differences in static 
admittance measures were found between RA and NC groups.  The static admittance 
values reported were still within normal limits.  Similarly, studies that reported 




classify the tympanogram.  Elwany et al. (1986) and Öztürk et al. (2004) reported 
over 50% of individuals in the RA groups had type As tympanograms, but the values 
considered abnormal are not specified.   
The variability across studies may also reflect gender differences, because 
women have lower static admittance values than men (Margolis & Heller, 1987).  
Most studies used age- and gender-matched normal control groups to help reduce 
potential confounding factors; however, the trend of lower static admittance may 
reflect the higher prevalence of females involved in RA research. 
Essentially, most studies conducted on RA reported no differences in acoustic 
reflex thresholds, consistent with the present results. One study reported prolonged 
acoustic reflex latency in 10% of RA participants ear (N = 45).  This may be an 
indicator of subtle joint involvement, and further analysis of the mechanics of the 
acoustic reflex may be warranted. 
Multi-frequency Tympanometry  
 
The RA group had a significantly lower resonant frequency than the NC 
group, which suggests an increased laxity of the middle ear system or an increased 
effect of mass on the middle ear system.  A mean resonant frequency of 
approximately 1000 Hz has been reported across studies using a frequency sweep 
method on commercially available GSI middle ear analyzers (Hanks & Rose, 1993; 
Margolis & Goycoolea, 1993; Valvik et al., 1994).  Valvik et al. (1994) reported a 
90% range for middle ear resonance of 650-1500 Hz.  In the present study, 9/38 ears 
in the RA group and 2/38 ears in the NC group had a resonant frequency below 650 




above 1500 Hz.  The NC group had a mean of 967 Hz and was comparable with 
normative data.  However, the RA group had a mean resonant frequency of 791 Hz, 
which was shifted toward the lower end of the range established by existing 
normative data (Valvik et al., 1994).   
Other middle ear measurements conducted within individuals were usually 
consistent with the resonant frequency results, as demonstrated by the pattern of 
notched tympanograms at 678- and 1000-Hz.  The prevalence of notching was not 
significantly different between groups; however, the RA group had more complex 
Vanhuyse patterns and more ears with notching, which is consistent with the resonant 
frequency findings.  Notching was not present in the low-frequency (226 Hz) 
tympanometric results.  A higher prevalence of notching in 660 Hz tympanograms in 
participants with RA has been reported by Moffat et al. (1977), Rosenberg et al. 
(1978), and Reiter et al. (1980). 
The lower resonant frequencies and more complex tympanometric 
configurations suggest the admittance of the middle ear system may be mass 
dominated in participants with RA.  Increased mass dominance is consistent with an 
increased laxity of the middle ear system in participants with RA.  The limited 
research previously conducted using multi-frequency tympanometry in participants 
with RA reported an opposite finding, and suggested an increased stiffness in the 
middle ear system (Biasi et al., 1996; Colletti et al., 1997) or no difference from 
normal ears (Frade & Martin, 1998).  Similar to the current study, these researchers 




groups, and only observed a sensorineural hearing loss when hearing loss was present 
(Biasi et al., 1996; Colletti et al., 1997). 
Biasi et al. (1996) and Colletti et al. (1997) found a higher resonant frequency 
in the RA group compared to the NC group.  The test methods differed from those in 
the current study, in which a frequency sweep at a positive pressure (+200) using a 
GSI middle ear analyzer was used.  In comparison, Biasi et al. (1996) and Colletti et 
al. (1997) determined resonant frequency by using a Virtual 310 middle ear analyzer, 
a negative to positive pressure sweep from –500 to +400 daPa, and frequency sweep 
for each air pressure value in 12.5 daPa steps.  The resonant frequency was 
determined by the first frequency in which notching occurred in the susceptance 
tympanogram.  The median values found by Biasi et al. (1996) and Colletti et al. 
(1997) were 1120 and 1250 Hz in the RA group, compared to 1000 and 1120 Hz in 
the matched NC group, respectively.  Significant differences between groups were 
reported in both studies.  However, individuals with RA in both studies presented 
with both abnormally low and high resonance, and results were not directional (Biasi 
et al., 1996; Colletti et al., 1997).  Other researchers have reported artifact and 
unreliable results from using a negative to positive pressure measurement method 
(Holte, 1996; Shahnaz & Polka, 1997). Due to differences in measurement 
procedures, it is difficult to make comparisons across studies.  Resonant frequency 
will vary based on the method and type of equipment used.  The method chosen for 
the present study was selected because frequency sweep techniques and a positive 




retest reliability than other methods (Holte, 1996; Shahnaz & Polka, 1997; Wiley, 
Cruickshanks, Nondahl, & Tweed, 1999).   
Frade and Martin (1998) used methods and equipment identical to the present 
study in order to determine resonant frequency.  These researchers made comparisons 
to existing normative data as opposed to a control group and found the mean resonant 
frequency in 37 individuals with RA was 998 Hz.  This is higher than what was 
obtained by the current study, but when Frade and Martin separated the RA 
population into groups based on disease activity, individuals with inactive disease 
staging had a significantly lower resonant frequency than individuals with active 
disease.  The lower resonant frequency obtained in the present study may also reflect 
the large number of individual in the RA group with low levels of inflammation and 
joint involvement. 
The lower resonant frequency among RA participants compared to NC 
participants is the opposite of expected effects of age and gender on resonant 
frequency (Wiley et al., 1999).  Wiley et al. reported no differences in resonant 
frequency with increasing age, but reported that older females have significantly 
higher resonant frequencies than older males, although the differences were small.  
The RA and NC groups in the current study were matched for gender, however, the 
sample was predominately female.  Observation of a low resonant frequency in the 
predominantly older female RA participants as opposed to a high resonant frequency 
strengthens the potential argument for the influence of RA on resonant frequency. 
The presence of abnormal middle ear results did not necessarily coexist with 




measurements and hearing loss are related, even when the two abnormalities do not 
coincide (Takatsu et al., 2005).  The current study did not observe any trends that 
abnormal middle ear findings and hearing loss coincided, similar to most existing 
literature (Biasi et al., 1996; Colletti et al., 1997; Öztürk et al., 2004; Raut et al., 
2001; Reiter et al., 1980).   
Some researchers who have reported differences in resonant frequency with 
no evidence of a conductive component attributed the differences to changes in the 
mobility of the ossicular joint (Biasi et al., 1996; Colletti et al., 1997). These 
researchers further suggested the stiffening of the ossicular joint could lead to long-
term damage to the cochlea due to a reduction of the protective mechanism of the 
middle ear (Colletti et al., 1997).  Moffat et al. (1977) attributed the increased laxity 
of the middle ear in the RA group to ligament anchorage of the ossicles.  Reiter et al. 
(1980) hypothesized that the changes to the ossicular joints affected the normal 
leverage function of the middle ear joints, increasing the mass of the system, and thus 
lowering the resonant frequency.  While these theories are reasonable based on what 
is known about how RA affects other synovial joints in the body, it is difficult to 
draw firm conclusions.  It can be hypothesized that subtle effects of the disease 
increase the mass dominance of the middle ear by effecting the leverage action of the 
middle ear joints.  The fact that a lower resonant frequency did not correlate with the 
number of swollen joints or ESR levels in the current study provides no additional 
support to this claim.  This hypothesis would need to be corroborated with 
examination of the middle ear joints, which is not practical in living humans.  




ear structures and potential reasons for abnormal middle ear findings.  The present 
study did not observe trends of lower resonant frequency corresponding with hearing 
loss.  Because other studies failed to correlate middle ear abnormalities and hearing 
loss, it seems the differences in middle ear sound transmission may not affect hearing 
sensitivity.   
While cases of middle ear abnormalities correlating with conductive hearing 
loss have been reported in cases of RA, these seem to be more rare instances.  Subtle 
but significant differences in the mass components of the middle ear systems in the 
RA group compared to the NC group would not necessarily be expected to cause 
hearing loss.  While some researchers have gone a step further to suggest that changes 
to the middle ear system resulting from RA may affect the protective mechanism of 
the middle ear, this theory does not seem reasonable, particularly because most of the 
hearing loss noted in the current study was within the age expected range.  Acoustic 
reflex thresholds more directly assess the protective functioning of the middle ear 
system, and should theoretically provide more information about any changes in this 
mechanism.  Normal acoustic reflex thresholds in RA participants are one of the few 
consistent findings reported across the literature.  Future studies examining the 
latency and amplitude of middle ear reflexes may provide further information.  
ER and DPOAE Measures  
 
Although differences in resonance frequency were observed between groups, 
differences in ER measurements between groups were not found.  ER measurements 
were very similar between groups, even though the RA group had a significantly 




ER, making subtle differences that do not cause conductive components difficult to 
identify.  Another factor might be that differences between individuals are averaged 
out in the analysis process.  Keefe et al. (1993) and Feeney and Sanford (2004) 
acknowledged concerns that averaged data reduced the depth of the point of least ER, 
because the deepest ER point occurred at various frequencies.  However, the current 
study compared the frequency at which the least amount of ER occurred, as well as 
the lowest amount of energy reflected, and still found no significant differences.  The 
discrepancy that significantly lower middle ear resonant frequencies were recorded in 
the RA group compared to the NC group, but that no differences were found 
comparing ER between groups, cannot easily be explained.  It would be expected that 
if there were a difference in the laxity or mass dominance of the middle ear system, as 
middle ear resonant frequency results suggest, it should also be reflected in ER data.   
Some individual results varied from the mean ER; however, this was true for ears in 
the NC group, as well.  These variances generally consisted of shifts in the peak of 
lowest frequency, and the variance observed in the included ears did not visually 
differ as much as excluded ears (e.g., negative middle ear pressure as displayed 
previously in Figure 7).  Figure 22 displays the average ER values obtained in this 
study compared to existing normative data. 
Average ER values measured in RA and NC groups in the present study were 
lower across frequencies from 250 – 2000 Hz and higher for frequency above 4000 
Hz compared to other normative data.  This difference is consistent for both groups.  
The differences may be due to equipment differences.  Shahnaz and Bork (2006) were 
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Voss & Allen, 1994 (N = 10) 
 
 
Figure 22.  Comparison of group mean ER values as a function of frequency across 
different studies.  ER values used for Keefe et al. (1993) and Voss and Allen, (1994) 









system and their data most closely resemble those from this study.  Figure 23 
compares mean ER data obtained in the current study to the 95th percentile range 
obtained by Shahnaz and Bork (2006).  Although the mean ER slightly differed 
compared to other studies as shown in Figure 22, the curve was within the 95% range 
based on data obtained from 126 ears using the Mimosa system as shown in Figure 23 
(Shahnaz & Bork, 2006).  However, the ER values in the present study, especially at 
the low frequencies, are very close to the edge of this range.  Differences may also be 
attributed to method.  Shahnaz and Bork (2006) used one test run for analysis, 
compared to the present study, which found the mean of three test runs.  Although the 
deviation from different test runs in the current study was small, these efforts helped 
to ensure test-retest reliability within each individual and may explain some, albeit 
most likely small, differences when comparing studies. 
Another factor that likely contributed to the ER differences seen in the present 
study is age.  Feeney and Sanford (2004) also demonstrated a significant decrease in 
ER from 794 – 2000 Hz, and significantly higher ER at 4000 Hz in their sample of 
older adults. The normative data obtained by Shahnaz and Bork (2006) included 126 
adults (237 ears) although inclusion criteria did not specify a requirement for TPP, 
and the individuals included were younger adults (20 – 32 years) than those in the 
current study. The current study carefully controlled for TPP and included older 
adults, which may contribute to the difference in ER between studies.  Despite the 
observable differences compared to normative data, the general shape is consistent 
across studies, unlike in pathological ears (Feeney et al., 2003). 



























Figure 23.  Group comparison of mean ER curves obtained for the RA and NC 
groups in the current study, compared to the 95% range for normative data from 











between the RA and NC groups.  Halligan et al. (2006) also reported no significant  
differences between groups in TEOAEs at 1000, 1500, 2000, 3000, and 4000 Hz. In 
contrast, Salvinelli et al. (2006) reported a significant difference in TEOAE 
reproducibility and level between RA and NC groups; however, their otologic 
screening criteria were not as stringent as in this and other studies.  The DPOAE 
results in the present study were consistent with expected outcomes based on 
audiometric results obtained within individuals.  The individuals that failed the 
DPOAE screening in the present study had hearing loss and middle ear abnormalities 
(hypermobile tympanic membrane). 
RA Demographics 
 
Only limited information is available regarding the effects of rheumatic 
medications, but no known ototoxic effects have been reported (Kastanioudakis et al., 
1995).  Halligan et al. (2006) observed hearing loss in an increased number of RA 
participants who were taking hydroxychloroquine, a type of DMARD; however, in 
the current study, only two of the eight individuals with hearing loss in the RA group 
were taking this medication, compared to 7/21 from the overall group taking this 
medication.  Although the RA participants in the present study were on a variety of 
medication regimens, no observable trends were found regarding abnormalities in the 
auditory system and medication.  This is consistent with the findings of other 
researchers who did not find correlations between medications used to manage RA 
and hearing loss (e.g., Kastanioudakis et al., 1995; Takatsu et al., 2005). 
Mixed results have been reported about the level of involvement of RA 




correlated with poorer air-conduction thresholds at 4000-8000 Hz.  Individuals with 
long disease duration would typically be older participants, and would be expected to 
have more hearing loss as an effect of age. Therefore, it was necessary to partial out 
age in the analysis, and a significant relationship was still found. However, due to the 
small sample size in this study, two older individuals with hearing loss and 
longstanding disease duration may have potentially skewed the correlation data.  
When correlations were repeated without these two individuals, no significant 
correlations were observed.  However, these individuals had hearing thresholds 
poorer than expected based on their age and their exclusion was not warranted.  
Because the sample size in the current study is small, individuals such as these may 
have a greater impact on overall results than in larger sample sizes and this 
correlation should be viewed cautiously.  In contrast, other studies did not find a 
correlation with disease duration and hearing loss (e.g., Takatsu et al, 2005).  Future 
studies might examine the hearing in children with juvenile RA, which may enable 
researchers to differentiate effects of age and the effects of RA on audiological 
measures.  Giannini et al. (1997) found children with juvenile RA had significantly 
higher mean resonant frequency than a control group of children.  Audiometric 
measures were not obtained in their study, but their results helped to suggest an effect 
of RA on middle ear resonant frequency independent of age.   
Other factors to consider are the variability in disease involvement with RA.  
RA can affect different joints in different individuals, and can have varying levels of 
involvement and inflammation within the same individual.  Factors such as disease 




comparisons difficult across the literature (Kakani et al., 1990; Öztürk et al., 2004; 
Raut et al., 2001).  Based on the results presented in the current study in Table 1, 
most of the individuals with RA had low levels of disease involvement reflected by a 
lack of swollen joints, and inflammation levels that were not significant.  This may 
have contributed to the lack of hearing loss found in this study compared to the NC 
group.   
Only a few studies have reported significant correlations between markers of 
disease involvement and hearing loss. Takatsu et al. (2005) reported individuals with 
RA and sensorineural hearing loss had higher ESR levels than individuals without 
hearing loss.  Goodwill et al. (1972) reported individuals with RA that had nodules 
had significantly poorer hearing than those without nodules.  Frade et al. (1998) 
reported individuals with active disease staging had higher resonant frequencies than 
individuals with inactive disease staging.  Additionally, a case report by Nores and 
Bonfils (1988) showed a decrease in hearing in a person with RA associated with a 
flare-up, and improvement five months later following medical management of the 
disease through corticosteroids.  However, others have reported no correlations 
between hearing measures and medications, disease duration, or disease stage 
(Giannini et al., 1997; Halligan et al., 2006; Salvinelli et al., 2004).  
The present study found a correlation with increased disease duration and 
poorer audiometric thresholds.  These significant correlations should be viewed 
cautiously due to the small sample size, and that the data could be heavily influenced 
by trends of a few as opposed to trends of the group.  Further research with a larger 




Chapter 7:  Conclusions 
 
The nature and type of hearing loss in individuals with RA has been widely 
debated, and existing research has varied.  The potential causes of hearing loss in 
individuals with RA have been attributed to effects on the middle ear joints from the 
RA disease process, vasculitis or neuritis, or ototoxic medication.  While there has 
been consensus about potential causes of hearing loss, the reported extent and 
influence of RA on the middle and/or inner ear have been varied.   
Results from the current study revealed the RA group was no more likely to 
have hearing loss than the NC group.  There were no differences in air- and bone-
conduction thresholds between groups.  Audiometric results revealed only 
sensorineural hearing loss in both groups; no individuals presented with a conductive 
component.  The RA group, however, had a significantly greater number of 
thresholds poorer than the 95th percentile based on age and gender.  In particular, a 
large number of young participants with RA had thresholds worse than expected for 
their age.  These significant differences highlight the importance of considering age 
effects for both abnormal and normal hearing thresholds.  The individuals in the NC 
group with clinical hearing loss had thresholds that fell within the expected range for 
their age.  In comparison, younger RA participants had normal clinical hearing 
sensitivity, but their thresholds were poorer than the 95th percentile in their age group, 
occurring most frequently in the mid-frequency range (1000-2000 Hz). 
Resonant frequency was significantly lower for the RA group versus the NC 
group.  However, no other significant differences were found for other middle ear 




and multi-frequency static admittance). The presence of notching at 678- and 1000-
Hz tympanograms was not significantly different between groups, but the RA group 
had more complex notching patterns, which is consistent with resonant frequency 
findings.  Although a statistically significant difference was found with regard to 
resonant frequency, the difference between groups was slight.  The lower resonant 
frequency is consistent with an increased in laxity or mass dominance of the middle 
ear system. However, because this was the only abnormal middle ear finding, it is 
difficult to draw strong conclusions.  
The differences in middle ear sound transmission implied by a lower mean 
resonance frequency in the RA group were not corroborated by ER measures.  No 
differences in ER measurements were found between the RA and NC group.  There is 
a broad range of normative data for ER, and limited research has been conducted to 
date.  Additional research is needed with larger samples to provide information about 
ER changes in ears with middle ear disorders.  In addition, no differences in DPOAE 
levels were found between the RA and NC group. 
Longer RA disease duration correlated with high-frequency air-conduction 
thresholds.  Due to the small sample size, these significant findings may have been 
skewed by a few select individuals and should be viewed cautiously.  The presence of 
abnormal middle ear measurements and hearing loss did not coincide in the current 
study.  This suggests that subtle middle ear differences in this population do not 
necessarily manifest as hearing loss.  This may explain why audiological 
considerations are often overlooked in the RA population.  The differences may be 




possible from previous studies, but may be rare.   It is difficult to draw strong 
conclusions about the underlying mechanism of change in the auditory system in 
individuals with RA. 
Currently, only pilot or preliminary studies have been conducted examining 
the effects of the disease process within individuals over time.  The majority of 
research on RA and hearing loss and middle ear function has utilized a cross-sectional 
design, and therefore, longitudinal studies would help to provide additional 
clarification.  Testing individuals when they first present with symptoms would help 
to provide results before and after treatment and about potential ototoxic effects of the 
medications often prescribed in this population.  Additional studies examining a 
greater number of individuals with active RA would provide information about the 
correlation between RA and audiological manifestations.  Longitudinal studies in 
individuals with active RA could help reveal whether effects are transitory or 
permanent, and, associated with flares in disease involvement. Additional studies are 
needed to examine younger adults with RA and an earlier onset of hearing loss than 
in the normal population.  The significant findings in this study show the importance 
of monitoring individuals with RA for potential audiological manifestations, and 
suggest the possible inclusion of an audiological evaluation in the test battery for 




























General Health Questionnaire 
 
Participant Number: _________  Date: ___________ 
 
Age: _______  Sex: (circle) Male     Female      
 
Race: (circle)  
African American       Asian           Caucasian           Hispanic               Pacific Islander  
       Native American                   Other___________________         
 
Responses may be reviewed orally for any necessary clarification. 
Please check the appropriate response (yes or no) to each question: 
 Yes No
1. Have you been clinically diagnosed with rheumatoid arthritis (RA) 
by a physician?  
If you answer “Yes,” please skip questions #2-10. 
  
2. Do you experience morning stiffness in and around the joints, 
lasting at least 1 hour? 
  
3. Do you have tender, warm, swollen joints?   
4. Do you have joint inflammation affecting the wrists, hands or 
fingers? 
  
5. Do you have simultaneous involvement/inflammation of the same 
joint area on both sides of the body? Symmetrical arthritis? 
  
6. Do you have rheumatoid nodules?   
7. Have you tested positive for a serum rheumatoid factor?   
8. Do you experience joint pain or stiffness?   
9. Have you had radiographic images that show erosions or bony 
decalcification of the hands or wrist? 
  
10. Has anyone in your family been diagnosed with rheumatoid 




11. Have you previously been diagnosed with hearing loss?   
12. Do you have a history of ear infections?   
13. Have you had any medical problems involving your ears?     
14. Have you had any surgeries involving your ears, nose or throat?   
15. Have you had an upper respiratory infection within 30 days?   
16. Do you have sinus problems?   
17. Do you have a history of noise exposure (e.g. military service, 
occupational noise)? 
  
18. Do you have ringing or sounds in your ears (tinnitus)?   
19. Do you experience problems with dizziness or balance?   












21. Have you sustained any type of head injury or trauma?   
22. Do you have any head or neck abnormalities that have been 
present since birth? 
  
23. Have you been diagnosed with any neurologic disease?   
24. Have you ever been diagnosed or treated for cancer?   
25. Have you ever been diagnosed with any other serious illness(es)?   
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